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Background. In 2013 alone, more than 4% (3.9 million) of patients discharged from a 
hospital were readmitted. Anemia following a surgical procedure is associated with early 
hospital readmission.   
Purpose/Aims.  The following were specific aims of this dissertation:   
• Aim 1. To develop an operational definition of the term condition-based 
maintenance as applied to health care and discuss the applicability and 
effectiveness of condition-based maintenance within health care. 
• Aim 2. To identify the number of adult patients undergoing elective open-heart 
surgery with preoperative anemia.   
• Aim 3. To examine the relationship between preoperative anemia, 
sociodemographics, and 30-day hospital readmission rates among postoperative 
open-heart adult patients.  
• Aim 4. To explain the development and impact of the Hospital Readmissions 
Reduction Program (HRRP) and discuss the political, social, and economic 
implications of CABG as a newly targeted condition within the HRRP. 
Approach. To address aim 1, the Walker and Avant model for concept analysis was used 
to review and analyze relevant literature, create a basic operational definition, and clarify 
related concepts. To address aims 2 and 3, a retrospective cross‐sectional study was 
conducted using the STS Database to identify 1,353 surgical cases between August 2014 
and July 2018. Cross-tabs and multivariable logistic regression analysis were used to 




readmission. To address aim 4, a policy analysis was performed in accordance with 
Bardach and Patashnik’s procedure. 
Findings. From the concept analysis process, the notion of condition-based maintenance 
emerged, holding promise in advancing symptom science through development of 
personalized strategies to treat and prevent adverse symptoms of illness.    
The prevalence of preoperative anemia was 43.7% (n = 591), and 177 (13%) had a 
30-day hospital readmission. Patients with preoperative anemia had 1.88 (95% CI 1.36, 
2.58) times higher odds of being readmitted. Through policy analysis, a correlation 
between insurance and 30-day hospital readmission following a CABG procedure was 
identified. Currently, penalty programs may be adjusted to better capture 
sociodemographic differences. 
Implications. The findings from this study suggest preoperative anemia is associated 
with increased risk for 30-day hospital readmission. These results provide a basis for 
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Background and Significance 
In 2013, more than 4% (3.9 million) of patients discharged from a hospital were 
readmitted, costing the health care sector $52 billion (Fingar & Washington, 2015). 
Anemia following a surgical procedure has been associated with early hospital 
readmission (Merkow et al., 2015). However, identification of anemia in preoperative 
open-heart patients as an independent predictor of 30-day hospital readmission is 
unknown.   
Decreasing readmissions among the postoperative coronary artery bypass graft 
(CABG) population through increased accountability efforts designated by the Hospital 
Readmission Reduction Program (HRRP) are likely to have profound effects similar to or 
perhaps greater than other established targeted conditions set by the Centers for Medicare 
and Medicaid Services (CMS). In fiscal year (FY) 2013, the maximum penalty for excess 
30-day hospital readmission was set at 1%. The penalty increased to 2% in FY 2014 and 
reached a cap of 3% in FY 2015 that remains in place today. Historically, the health care 
system has taken extensive time to implement comprehensive programs to address patient 
outcomes.  
Research Question and Aims 
The purpose of this research study was to examine the prevalence and 
postoperative outcomes of preoperative anemia among adults undergoing open-heart 
surgery. To better understand this relationship, the research question of interest is, What 
is the relationship between preoperative anemia (hemoglobin<13g/dL, for 6 months) 
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and 30-day hospital readmission among adult postoperative open-heart patients? The 
following specific aims of this study were used to address the research question:   
• Aim 1. To develop an operational definition of the term condition-based 
maintenance as applied to health care and to discuss the applicability and 
effectiveness of condition-based maintenance within health care. 
• Aim 2. To identify the number of adult patients undergoing elective open-heart 
surgery with preoperative anemia.   
• Aim 3. To examine the relationship between preoperative anemia, 
sociodemographics, and 30-day hospital readmission rates among postoperative 
open-heart adult patients.  
• Aim 4: To explain the development and impact of the Hospital Readmissions 
Reduction Program (HRRP) and discuss the political, social and economic 
implications of coronary artery bypass grafting as a newly targeted condition 
within the HRRP. 
Literature Review 
Hospital Readmissions 
The U.S. Patient Protection and Affordable Care Act (ACA) has forced hospitals 
to reexamine health care delivery with the initiation of the HRRP in 2012. Notably, the 
HRRP ties patient outcomes to reimbursement for care provided and allows the Centers 
for Medicare & Medicaid Services (CMS) to reduce reimbursement payments to 
hospitals with high readmission rates (CMS, 2016). Consequently, since the initiation of 
the HRRP, concentrated efforts have focused on the reduction of morbidity, as it has been 
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shown to decrease costs (Keenan et. al, 2008). Interest in identifying readmission 
measures specifically related to surgical patients has grown.   
Unplanned Readmissions 
Unplanned readmissions to the hospital are increasingly being used as a quality 
metric of provider performance. Merkow et al. (2015) utilized a dataset from the 
American College of Surgeons National Surgical Quality Improvement Program (ACS 
NSQUIP) to examine the timing and reason for unplanned readmissions. This prospective 
study captured 498,875 patients from 346 ACS NSQUIP associated institutions who 
underwent bariatric surgery, colectomy, proctectomy, hysterectomy, total hip/knee 
arthroplasty, ventral hernia repair, and lower extremity vascular bypass in 2012. Across 
all procedural groups, 5.7% had an unplanned readmission with an average length of stay 
of 1 day and a median time to readmission of 8 days. Surgical site infection was the 
leading cause of readmission (19.5%) with ileus or intestinal obstruction as the second 
(10.3%). Bleeding and anemia were analyzed together, making up the third leading cause 
of readmission at 4.3% (Merkow et al., 2015). Kassin et al. (2012) found a much higher 
rate of readmission (11.3%) among 1,442 general surgery patients admitted between 
2009 and 2011 at a single academic center. Findings showed an occurrence of 
postoperative complications was most closely associated with 30-day hospital 
readmission (Kassin et al., 2012). While this data is only representative of the surgical 
procedures it examined, it provides a baseline with which to compare other surgical 






Open-heart surgery yields a very high index cost of more than $149,000 and has 
an associated length of stay averaging 9.2 days (Mozaffarian et al., 2016). Historically, 
readmission related to cardiac surgery has been significantly high (13-18%) and has yet 
to waiver (Hannan et al., 2011; Sargin et al., 2016). In 1999, a multihospital study 
examined rates and common causes of hospital readmission in patents who underwent 
coronary artery bypass graft surgery in New York. This was the first study of its kind 
(Hannan et al., 2003). Upon examination of the identified diagnosis-related groups 
(DRGs), surgical site infection was listed as the top cause of readmission (28%), 
followed by heart failure (16%). Anemia was identified as the primary cause of hospital 
readmission in just 0.5% of all cases (Hannan et al., 2003). Compared to Merkow et al. 
(2015) who noted a 5.7% readmission rate across six other identified surgical procedures, 
the average rate of hospital readmission among the open-heart surgery group was 12.9% 
(Hannan et al., 2003). What is not known is how many patients with a primary diagnosis 
of heart failure were also anemic or iron-deficient. Iron-deficiency with or without 
anemia plays a substantial role in the prognosis of heart failure that is often left untreated. 
In a retrospective study with 2,664 patients, Sargin et al. (2016) compared CABG 
procedural outcomes with an alternate method for myocardial revascularization, 
percutaneous coronary intervention (PCI), and found there was no statistically significant 
difference in 30-day hospital readmissions (18.3% and 15.2%, respectively). Although 
several risk factors for readmission were identified through multivariate analysis, anemia 
was not taken into consideration and thus would not have been identified as a risk factor.   
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Hospital readmissions, particularly following cardiac surgery, are costly to both 
the patient and the organization providing service. In a 2009 study in Regione Piemonte, 
Italy, 2,067 open-heart patients were monitored during their stay and for six months 
following their procedure. The purpose was to examine ICU interventions and patient 
conditions using hazard models and regression analysis to identify DRGs that may 
predict hospital readmission and reimbursement costs. Zadra and Caruso (2015) found of 
the patients monitored, 528 (25.5%) had at least one hospital readmission event. Factors 
during the index hospitalization identified as strong prognosticators of a hospital 
readmission included length of stay, tracheostomy, heart or kidney failure, infection, and 
the use of intra-aortic balloon pumps (IAPB) or extracorporeal membrane oxygenation 
(ECMO) machines (Zadra & Caruso, 2015). Identification of specific treatments and 
therapies as they relate to the predictability of hospital readmission is an important 
contribution to the working knowledge of hospital readmission prediction models.   
Predictive Models   
One strategy to improve morbidity and reduce hospital readmission is to first 
identify patients who are potentially at high-risk. Nashef et al. (1999) first published the 
European System for Cardiac Operative Risk Evaluation (EuroSCORE) in 1999. This 
evaluation instrument has aided cardiothoracic surgeons in surgical decision-making, 
preoperative informed consent, quality assurance, and health care management (Yap et 
al., 2006). The validity of the EuroSCORE has been tested in tens of thousands of 
patients and across other countries such as Spain, Turkey, and Australia. While some 
studies have found the validity to be satisfactory, overestimation of mortality among 
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high-risk patients has been consistent, requiring clinicians and researchers to continue to 
work on finding a more meaningful method of risk evaluation.   
Researchers in Columbia considered adding hemoglobin and B-type natriuretic 
peptide (BNP) to the EuroSCORE to see if the predictive power of morbidity and 
mortality would be increased for both index hospitalizations and 60-day readmissions. 
Hernández-Leiva, Dennis, Isaza, and Umaña (2013) reviewed data on 554 patients, 
looking at the predictability of hemoglobin and BNP independently against the 
EuroSCORE, then they incorporated the variables into the EuroSCORE itself. Findings 
showed either high preoperative BNP or low hemoglobin are associated with independent 
risk of postoperative outcomes. When both variables were integrated into the 
EuroSCORE, an increase in the prediction of morbidity was noted; however, the 
prediction of mortality was insignificant. A study published in 2013 described a 
comparison analysis between the EuroSCORE, EuroSCORE II, and the Society of 
Thoracic Surgeons (STS) risk models on Turkish patients undergoing coronary artery 
bypass grafting procedures. Findings indicated an overestimation of mortality using the 
EuroSCORE II; in contrast, the EuroSCORE and STS models estimated mortality well 
(Kunt et al., 2013).  
Espinoza et al. (2016) published a simplified risk prediction instrument, the 30-
Day Readmission Score, to improve the identification of patients who are high-risk for an 
early hospital readmission following open-heart surgery. The instrument was tested and 
validated in Argentina on more than 5,000 patients (AUC 0.639 [95% CI 0.606 to 
0.672]). The risk prediction included a review of the hematocrit value preoperatively, 
with a value of <35% preoperatively considered high-risk. Other variables included a 
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history of diabetes mellitus, minutes spent on-pump, highest serum glycemic level, and 
atrial fibrillation postoperatively. The authors admitted to poor exploration of 
preoperative anemia and discussed the association between acute kidney injury (AKI) 
and anemia, with supporting evidence that AKI is a precursor to other risk factors 
associated with hospital readmission. Based upon multivariate analysis results, neither 
preoperative renal failure nor postoperative acute kidney injury were strongly associated 
with hospital readmission. However, upon examination of preoperative anemia alone, 
uni- and multivariate analysis showed significant associations with hospital readmission 
(Espinoza et al., 2016).  
Anemia Definition and Prevalence 
The World Health Organization (WHO) provided a definition of anemia in 1968 
as a hemoglobin <13g/dL for males and <12g/dL for non-pregnant females, all 15 years 
and older and measured at sea level (Cappellini & Motta, 2015; Shander & Roy, 2016; 
WHO, 2015).  This definition is broken down further by the WHO to describe three 
differentiating levels of anemia: mild (men 11.0-12.9g/dL; women 11.0-11.9g/dL), 
moderate (8.0-10.9g/dL) and severe (<8.0g/dL), respectively. Iron deficiency is a 
common global issue that, if left untreated, may lead to anemia (WHO, 2011). Multiple 
chronic medical conditions are attributed to iron deficiency, including chronic kidney 
disease, Parkinson’s disease, inflammatory bowel disease, rheumatoid arthritis, and heart 
failure (HF; Toblli, Cao, Rivas, Giani, & Dominici, 2016). Cardiac muscle depends on 
iron for metabolism and mitochondrial function. 
Le (2016) reported a prevalence rate of anemia in the U.S. population (excluding 
pregnant women) at 5.6%, with 1.5% meeting criteria for moderate-severe anemia. 
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Anemia was higher in non-pregnant females compared to males (7.6% vs. 3.5%) with the 
exception of persons 80–85 years, where twice as many males had anemia (26.3% vs. 
15.2%). The prevalence of anemia among hospitalized patients was high (10.4%). Over a 
10-year period, from 1999-2008, the rate of hospitalized patients with anemia climbed 
steadily and continues to increase (Kim, Connell, McGeorge, & Hu, 2015; Rachoin, 
Cerceo, Milcarek, Hunter, & Gerber, 2013).   
Preoperative Anemia   
Throughout various studies, investigators have consistently found the prevalence 
of preoperative anemia to be much higher (22%-54.4%) than that of the general 
hospitalized patient population (10.4%; Hung, Besser, Sharples, Nair, & Klein, 2011; 
Karkouti, Wijeysundera, Beattie, & Reducing Bleeding in Cardiac Surgery (RBC) 
Investigators, 2008; Rachoin et al., 2013). Preoperative anemia has been identified as an 
independent prognosticator of postoperative adverse events. Clinical evidence, as stated 
in the literature, associates preoperative anemia with adverse outcomes such as increased 
transfusions, perioperative death, and prolonged length of stay (Gupta et al., 2013; 
Hallward, Balani, McCorkell, Roxburgh, & Cornelius, 2016; Hung et al., 2011; Karkouti 
et al., 2008; Rachoin et al, 2013). A large study conducted at Veteran’s Affairs from 
1995-2005 examined 36,658 patients who underwent on-pump CABG surgery. Results 
showed a strong association between hemoglobin and serum creatinine, with serum 
creatinine being the stronger predictor of adverse postoperative outcomes (Bell et al., 
2008). These studies however, failed to examine the relationship between postoperative 
anemia and hospital readmission.  
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The prevalence of preoperative anemia in patients undergoing cardiac surgery 
ranges from 26% to 35% (Karkouti et al., 2008; Kulier et al., 2007). Older adults aged 
80–85 years had the highest proportion of anemia (19.4%) and moderate-severe anemia 
(4.0%; Le, 2016). Considering octogenarians make up approximately 8% of cardiac 
surgery cases and are increasingly being referred, it is imperative to consider anemia 
during the preoperative assessment (Wang et al., 2014).   
Preoperative Anemia Treatment 
Studies have shown administration of intravenous (IV) iron can provide 
protection for heart tissue and prevent structural remodeling (Dong et al.,2005; Naito et 
al., 2009). Ferric carboxymaltose (FCM), a relatively new IV medication that has been 
shown to increase hemoglobin in patients undergoing elective orthopedic surgeries, has 
also been linked to much lower incidence of administration-related adverse events 
compared to traditional oral iron supplements (Rineau, Chaudet, Carlier, Bizot, & 
Lasocki, 2014). Similar results were found in a study conducted with patients diagnosed 
with colon cancer; Calleja et al. (2016) found preoperative administration of FCM 
effectively reduces the need for red blood cell transfusion and reduces length of stay for 
patients undergoing elective surgery. 
Dowidar, Ezz, El Dorf, and Kasem (2016) examined the effects of combined 
supplementation methods on hematocrit using oral iron and recombinant human 
erythropoietin (rHuEPO) as an intervention. Participants were patients undergoing an 
elective myomectomy procedure and were randomly assigned to three groups: control, 
oral iron, and oral iron with rHuEPO injections. Researchers noted a reduction in blood 
product transfusion among patients who received oral iron and rHuEPO injections. Both 
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FCM and rHuEPO show promising results for cardiac surgery patients and future 
research should examine effectiveness of these treatments among cardiac surgery 
patients. Currently, limited literature exists with mixed findings.   
Theoretical Framework 
 It is important to understand how anemia may develop, the impact of chronic 
anemia on the human body, and the symptoms a patient may experience as a result. This 
study was informed by the physiological processes of chronic anemia and was supported 
by symptom burden theory (Gill, Chakraborty, & Shelby, 2012). 
Symptom Burden: Etiology  
The term symptom was first known to be used in 1541 and is derived from late 
medieval Latin synthoma, based on Greek sumptōma (“chance, symptom”) from 
sumpiptein (“happen”). A current definition includes “a physical or mental feature that is 
regarded as indicating a condition of disease, particularly such a feature that is apparent 
to the patient” (Symptom, n.d.). As a noun, burden is defined as “a duty or misfortune 
that causes hardship, anxiety, or grief; a nuisance.” The first known use of the Middle 
English term came prior to the 12th century, from “Old English byrthen; akin to Old 
English beran (“to carry”; Burden, n.d.).  
Symptom Burden: Operational Definition 
Efforts to define symptom burden have largely focused around the oncology 
patient. Cleeland (2007) defined symptom burden as “the sum of the severity and impact 
of symptoms reported by a significant proportion of patients with a given disease or 
treatment” (p. 17).  Gill et al. (2012) took a different approach and were the first to 
conduct a study asking oncology patients to provide a definition themselves. A total of 58 
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patients identified what symptom burden meant to them personally, in addition to rating 
their perceived symptom burden during the previous week. After analysis of the 
participants’ responses, a definition for symptom burden was identified as “a loss of 
functional abilities along with psychological suffering, both are affected by the impact of 
specific severe symptoms” (2012, p. 88). The definitions of symptom burden used among 
the oncology population are increasingly being used in patients suffering from chronic 
illness. Bekelman et al. (2009) found patients with symptomatic heart failure had the 
same, if not worse, symptom burden, depression, and spiritual well-being compared to 
patients with advanced cancer. In this study, symptom burden is defined as “the 
subjective, quantifiable prevalence, frequency, and severity of symptoms placing a 
physiologic burden on patients and producing multiple negative, physical, and emotional 
patient responses” (Gapstur, 2007).   
Conceptual Framework 
Anemia and Cardiac Remodeling  
To better understand how anemia may lead to symptomatic heart failure and 
ultimately open-heart surgery, a review of the pathophysiology is provided.  
Decrease in red blood cell production & oxygen delivery. Patients with chronic 
kidney disease, low iron, or vitamin deficiency are at increased risk for low red blood cell 
production. With decreased red blood cell production, oxygen-carrying capacity is 
limited.  
Compensatory state. Over time, low iron stores may lead to cardiac remodeling, 
including left ventricular (LV) hypertrophy, dilation, and diastolic dysfunction 
(Jankowska, von Haehling, Anker, Macdougall, & Ponikowski, 2012; Toblli et al., 2016). 
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It has been suggested there is increased generation of reactive oxygen and nitrogen 
species among patients with heart failure. This oxidative/nitrosative stress may contribute 
to cardiac remodeling within the myocardium and ultimately lead to contractile failure 
(Madungwe, Zilberstein, Feng, & Bopassa, 2016). This remodeling compromises 
hemodynamics (increased blood volume, heart rate, stroke volume, and decreased 
afterload) and contributes to cardiac inflammation and fibrosis, leading to symptomatic 
heart failure with pulmonary congestion (Naito et al., 2009).    
Symptom burden. Patients with heart failure face several challenges leading to a 
decreased quality of life. As physical symptoms increase in severity, functional status 
decreases, hospital admissions increase, and psychological well-being diminishes (Alpert, 
2017; Buck et al., 2015). Patients may undergo open-heart surgery to improve symptoms 
through coronary revascularization, repair of valve regurgitation, and stenosis (Figure 
1.1).  
 
Figure 1.1. Conceptual framework: Anemia and heart failure symptom burden. 
 
Dissertation Approach Overview 
Papers providing a concept analysis, empirical study, and a policy analysis form 
the basis of this dissertation and are presented in Chapters 2, 3, and 4 respectively. 
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Paper I: Concept Analysis 
Chronic illness burdens patients, providers, and health care organizations. To 
confront this challenge, the National Institute of Nursing Research emphasizes the 
importance of identifying biological indicators, understanding the behaviors of 
symptoms, finding symptom precursors, and creating management algorithms. To 
support these aims, the Walker and Avant model for concept analysis was used to review 
and analyze relevant literature, create a basic operational definition, and clarify related 
concepts. From this analysis, condition-based maintenance emerged as a novel concept, 
holding promise in advancing symptom science through the development of personalized 
strategies to treat and prevent the adverse symptoms of illness. 
Paper II: Multisite, Cross-Sectional Study 
Anemia is linked to structural and functional cardiac dysfunction. As patients 
become burdened with symptoms, they are more likely to be referred to a cardiothoracic 
surgeon for structural repair of the heart. The purpose of this study was to describe the 
relationship between preoperative anemia (hemoglobin <13g/dl) and 30-day hospital 
readmission among adult postoperative open-heart patients.  
A retrospective, observational, cross-sectional study was conducted using the 
Society of Thoracic Surgeons National Database for Adult Cardiac Surgery to identify 
1,353 surgical cases between August 2014 and July 2018. Although retrospective studies 
are often criticized for their unmeasured confounding variables and bias, special care was 
taken to avoid such issues. This design allowed the investigator to identify whether adult 
patients who have preoperative anemia prior to elective open-heart surgery are at greater 
risk for an adverse outcome, namely a 30-day hospital readmission, compared to those 
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without preoperative anemia. Data extracted allowed the investigator to describe the 
relationship between elective open-heart surgical outcomes and sociodemographics 
across three community hospitals in San Diego County. Lastly, the study design allowed 
for examination of the prevalence and relative risk of preoperative anemia among adult 
patients undergoing elective open-heart surgery.   
Sample and sampling. Identifiers were provided through a cross-sectional 
sample taken between August 2014 and July 2018 of cases having undergone open-heart 
surgery at any of three acute care not-for-profit hospitals that are part of a multicenter 
health care system located in southern California. Cases were extracted from the Society 
of Thoracic Surgeons National Database for Adult Cardiac Surgery.  
Inclusion criteria.  
1. Persons 18 years of age and older 
a. Persons less than 18 are excluded as the majority of open-heart surgical 
procedures during this timeframe are related to congenital defects. 
2. Elective or urgent surgery  
a. Elective surgery is defined as a procedure that is scheduled in advance 
because it does not involve a medical emergency. 
b. Urgent is defined as a surgery that must be done to preserve the patient's 
life, but does not need to be performed immediately. 
3. Open-heart surgery procedure(s) 
a. Frequently conducted procedures include coronary artery bypass grafting, 
mitral valve repair/replacement, aortic valve repair/replacement, and any 




1. Emergent surgery 
a. Emergent open-heart procedures naturally carry a higher risk of morbidity 
and mortality both in-hospital and post-discharge.   
2. Infrequent open-heart surgical procedures  
a. Infrequent procedures such as tricuspid valve repair/replacement and 
pulmonary valve repair/replacement are excluded as they are associated 
with significant early and late mortality. 
3. Previous heart transplant 
a. A transplanted heart increases the risk of an adverse outcome in patients 
undergoing CABG or valve replacement due to several factors (e.g. 
increased scar tissue, decrease immune function). 
4. Known congenital heart defect 
a. Congenital heart defect, repaired or unrepaired, increases the risk of an 
adverse outcome in patients undergoing CABG or valve replacement. 
5. Died prior to discharge 
Procedures. Cases were extracted from the Society of Thoracic Surgeons 
National Database for Adult Cardiac Surgery for only the three participating facilities, 
with surgeries between August 2014 and July 2018. The primary investigator validated 
the completeness and quality of the abstracted data by validating a random sample of 
cases. Cases included in the study were followed long enough for the outcome of interest 
to occur. The outcome is independent of health care personnel judgment, since patient 
reported outcomes (e.g., 30-day hospital readmission, and death) are reported separately. 
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Measurement. Table 1.1 presents the variables measured in the study. 
Table 1.1 
Study Variables 
 Variable Name Data Type 
1 Patient Age Continuous  
2 Patient Gender Categorical 
3 Patient Zip Code Categorical 
4 Race Ethnicity Categorical 
5 Hospital Name Categorical 
6 Primary Payor Categorical 
7 Primary Payor Medicare Fee for Service Categorical 
8 Admit Source Categorical 
9 Body Mass Index Continuous 
10 Diabetes Categorical 
11 Dyslipidemia Categorical 
12 Hypertension Categorical 
13 Tobacco Use Categorical 
14 Prior Cerebrovascular Accident Categorical 
15 Preoperative Anemia – 4 Classifications Categorical 
16 Preoperative Anemia – 2 Classifications Categorical 
17 Hemoglobin Continuous 
18 Last Creatine Level Continuous  
19 Total Albumin Continuous  
20 Last A1c Level Continuous  
21 Previous Cardiac Intervention Categorical 
22 Prior Myocardial Infarction Categorical 
23 Cardiac Presentation Symptoms on Admission Categorical 
24 ADP Inhibitors within 5 days Categorical 
25 Aspirin within 5 days Categorical 
26 Glycoprotein IIb/IIIa Inhibitor within 24hrs Categorical 
27 Anticoagulants within 48hrs Categorical 
28 Warfarin/Coumadin within 5 days Categorical 
29 Factor Xa Inhibitors within 5 days Categorical 
30 Novel Oral Anticoagulant within 5 days Categorical 
31 Thrombin Inhibitors within 5 days Categorical 
32 Thrombolytics within 48hrs Categorical 
33 Ejection Fraction Continuous  
34 Surgery Status Elective / Urgent Categorical 
35 Urgent Reason Categorical 
36 Perioperative Blood Products Categorical 
37 Perioperative Red Blood Cell Units Categorical 
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Table 1.1 (continued) 
 Variable Name Data Type 
 
 
38 Perioperative Fresh Frozen Plasma Units Categorical 
39 Perioperative Platelet Units Categorical 
40 Perioperative Cryoprecipitate Units Categorical 
41 Perioperative Antifibrinolytic Caproic Acid Categorical 
42 Perioperative Antifibrinolytic Tranexamic Acid Categorical 
43 Coronary Artery Bypass Categorical 
44 Cardiac Pulmonary Bypass Utilization Categorical 
45 Valve Procedure Categorical 
46 Aortic Valve Categorical 
47 Aortic Valve Procedure Categorical 
48 Mitral Valve Categorical 
49 Mitral Valve Procedure Categorical 
50 Postoperative Peak Glucose Continuous 
51 Postoperative Creatinine Level Continuous 
52 Postoperative Hemoglobin Continuous 
53 Postoperative Blood Products Categorical 
54 Postoperative Red Blood Cell Units Categorical 
55 Postoperative Fresh Frozen Plasma Units Categorical 
56 Postoperative Platelet Units Categorical 
57 Postoperative Cryoprecipitate Units Categorical 
58 Initial Intensive Care Unit Hours Continuous 
59 Readmission to Intensive Care Unit Categorical 
60 Postoperative Intra-Aortic Balloon Pump Categorical 
61 Postoperative Sternal Superficial Wound Infection Categorical 
62 Postoperative Deep Sternal Infection Mediastinitis Categorical 
63 Postoperative Conduit Harvest Categorical 
64 Postoperative Wound Intervention Procedure Categorical 
65 Postoperative Renal Categorical 
66 Postoperative Renal Dialysis  Categorical 
67 Postoperative Dialysis Required After Discharge Categorical 
68 Postoperative Cardiac Arrest Categorical 
69 Postoperative Atrial Fibrillation Categorical 
70 Mortality 30day Status Categorical 
71 Discharge Location Categorical 
72 Readmission 30day Hospital  Categorical 
73 Readmission Reason 30day Discharge Categorical 
74 Total Operating Room Time Continuous 
75 Admission to Discharge Length of Stay Continuous 
76 Surgery to Discharge Length of Stay Continuous 




Analysis. Aim 1 of the study was to identify the number of adult patients 
undergoing elective open-heart surgery with preoperative anemia. The primary endpoint 
is the prevalence of adult patients identified as having preoperative anemia (Hb <13g/dL) 
prior to open-heart surgery. Aim 2 of the study was to examine the relationship between 
preoperative anemia, sociodemographics, and 30-day hospital readmission rates among 
postoperative open-heart adult patients. The endpoint for this aim is the risk of 30-day 
hospital readmission following open-heart surgery among adult patients with 
preoperative anemia compared to those without. 
 Descriptive statistics were used to identify frequencies of variables. The number 
and rate of readmissions within 30-days of hospital discharge were first identified. 
Stratification by surgical procedure, comorbid illnesses, sex, age, ethnicity, and zip code 
followed. The hemoglobin concentrations were used as both continuous and categorical 
variables (i.e., <8g/dL, 8-10g/dL, 10.1-12.9g/dL, and ≥13 g/dL). Univariable associations 
between primary and secondary categorical variables and the hemoglobin concentration 
was assessed using the chi-square test or Fisher’s exact test as appropriate. Univariable 
associations for continuous variables were assessed using the analysis of variance. The 
variables found on univariable analysis to be significantly associated with the categorical 
outcomes were then included in multivariable logistic regression models. All reported p-
values are two-tailed, and a 0.05 significance level was used in final models. 
Paper III: Policy Analysis 
Open-heart surgery yields a very high index cost, more than $149,000 and has an 
associated length of stay averaging 9.2 days. Compared to all condition readmissions, 
CABG patients had the second highest average Medicare payment per readmission at 
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$8,136 per visit for an annual cost of $151 million. Implementation of the U.S. Patient 
Protection and Affordable Care Act (ACA) in 2010 provided government agencies with 
structures and processes to hold hospitals accountable for improving the quality of care 
delivered while reducing the associated astronomical health care costs.   
The aims of this policy analysis were two-fold: (a) to explain the development 
and impact of the Hospital Readmission Reduction Program (HRRP) and (b) discuss the 
political, social, and economic implications of coronary artery bypass grafting as a newly 
targeted condition within the HRRP. Peer-reviewed literature was gathered using 
PubMed and CINAHL databases. The paper is presented in accordance with Bardach and 
Patashnik’s eight-step policy analysis procedure. Additional information was retrieved 
from AARP, AHRQ, CMS, Commonwealth Fund, DHHS, HRSA, Kaiser Family 
Foundation, and the Library of Congress.  
Human Subjects 
Human subject protection oversight was provided by the Institutional Review 
Board of both the University of San Diego and the participating health care system. To 
safeguard obtained information, data were stored on a restricted, password-protected 
computer system.  
Implications for Nursing 
Organizations providing open-heart surgery must be prepared to redesign their 
programs to incorporate additional services (such as predictive models and care 
transitions programs) upstream to prevent negative downstream consequences such as 
hospital readmissions. Increased interprofessional collaboration will provide patients with 
enhanced comprehensive care throughout their hospitalization, even following them 
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home, thus optimizing patient recovery. Nurses, including clinical nurse specialists 
(CNSs), must be empowered to maximize their practice, creating a structure where care 
can be rendered effectively and efficiently throughout the patient’s stay. 
Summary 
Since the initiation of the HRRP, concentrated efforts focusing on the reduction of 
morbidity and readmissions have pushed hospitals to implement risk reduction programs 
at a much quicker pace, and results show favorable outcomes in decreased costs and 
improved quality of life (Keenan et. al, 2008). Through the addition of CABG as a 
targeted measure, it can be expected that readmission rates will decrease. However, 
sociodemographic data must be taken into consideration because many patients will 
present with multiple comorbidities and poor compliance, thus challenging what 
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Chronic illness burdens patients, providers, and health care organizations. To confront 
this challenge, the National Institute of Nursing Research emphasizes the importance of 
identifying biological indicators, understanding the behaviors of symptoms, finding 
symptom precursors, and creating management algorithms. To support these aims, the 
Walker and Avant model for concept analysis was used to review and analyze relevant 
literature, create a basic operational definition, and clarify related concepts. From this 
research, the notion of condition-based maintenance emerged as a novel concept, holding 
promise in advancing symptom science through the development of personalized 
strategies to treat and prevent the adverse symptoms of illness. 
 Keywords: condition-based maintenance, concept analysis, readmission, symptom 




Statement of Significance 
The condition-based maintenance model is simple and underpinned by the 
premise most equipment failures are preceded by certain signs, conditions, or indications. 
Research shows condition-based maintenance improves equipment health management, 
lowers life cycle costs, and prevents failures from occurring. Application of equipment-
related condition-based maintenance has been widely researched throughout various 
industries; however, use of condition-based maintenance has not been explored in 
relation to health maintenance among humans.  
This article advances the NINR’s focus on symptom science through the 
development of personalized strategies to treat and prevent the adverse symptoms of 
illness. It is anticipated this concept analysis will contribute to further identification of 
clinical signs of deterioration and accompanying interventions to prevent hospitalization 




Application of Condition-Based Maintenance in Health Care: A Concept Analysis 
Introduction 
In 2013, more than 4% of patients (3.9 million) discharged from a hospital were 
readmitted, costing the health care sector $52 billion.1 The U.S. Patient Protection and 
Affordable Care Act (ACA) has forced hospitals to reexamine health care delivery with 
the initiation of the Hospital Readmission Reduction Program (HRRP), which ties patient 
outcomes to reimbursement for care provided. In November 2012, the Centers for 
Medicare & Medicaid Services (CMS) began to reduce reimbursement payments to 
hospitals with high readmission rates.2 
In 2013, the National Institute of Nursing Research3 charged a group of symptom 
science experts with identifying research questions that could be used to advance nursing 
science. Experts discussed the importance of identifying biological indicators, 
understanding the behaviors of symptoms, finding symptom precursors, and creating 
management algorithms. In addition, experts strongly recommended leveraging 
technologies to improve symptom management and change the chronic illness trajectory 
through innovative care delivery models. When deriving a concept for analysis related to 
the topics of symptom science and hospital readmissions, concepts and models were 
examined from a wide range of industries that dealt with the general ideas of 
maintenance and failure within their field. Articles within engineering were 
overwhelmingly filled with various maintenance models. These models were examined 
and the lifespan of equipment and related maintenance was closely reviewed and 




Figure 2.1. Concept derivation from the engineering industry to health care. 
 
Condition-based maintenance originated in the 1940s when the Rio Grande 
Railway Company crafted the model to detect coolant and fuel leaks in a diesel engine's 
lubricating oil. Due to the overwhelming success of the model, the U.S. Army adopted 
and improved upon initial efforts, propelling the models popularity during the ‘50s, ‘60s, 
and ‘70s.4 The condition-based maintenance model is simple and underpinned by the 
premise most equipment failures are preceded by certain signs, conditions, or 
indications.5 Research shows condition-based maintenance improves equipment health 
management, lowers life cycle costs, and prevents failures from occurring.6 Application 
of equipment-related condition-based maintenance has been widely researched 
throughout various industries; however, condition-based maintenance has not been 
explored in relation to health maintenance in humans. Application of the condition-based 
maintenance model may prove relevant in reducing hospital readmission as it relates to 
the monitoring, identification, and treatment of specific disease processes before an 






The purpose of a concept analysis is to examine a particular term, carve out a 
clear definition, and ultimately describe its application within an identified context. The 
aim of this concept analysis paper is two-fold. The first aim is to develop an operational 
definition of condition-based maintenance as applied to health care; the second is to 
discuss the applicability and effectiveness of condition-based maintenance within health 
care.  
Method 
The paper is presented in accordance with Walker and Avant’s7 eight-step 
concept analysis procedure: (a) selecting a concept; (b) determining the aim and purpose 
of the analysis; (c) identifying the uses of the concept; (d) defining the attributes of the 
concept; (e) constructing a model case example; (f) creating borderline, related, and other 
case examples; (g) identifying the antecedents and consequences; and (h) defining the 
empirical referents. 
Literature was gathered using the PubMed, Wiley Interscience Journals, and 
Emerald databases. Over 420 articles were identified from the initial search for the years 
2010 through 2017 using the term condition-based maintenance. Limiters were applied 
that included full-text, peer-reviewed articles that were available in English, narrowing 
the volume of pertinent literature to 54 articles. Each article was then retrieved and 
reviewed for the definition, use, and key concepts of condition-based maintenance. Cited 
reference lists were also examined to identify additional relevant literature, resulting in 
six additional articles for a total of 60 articles reviewed. Of all the articles reviewed, 56 
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referenced the concept of condition-based maintenance and were used for further 
analysis.  
Results 
Uses of the Concept 
While literature from the field of engineering prevails, condition-based 
maintenance can also be found in automotive, aviation, defense, and manufacturing 
industries. Condition is a familiar term within health care literature, often referring to a 
patient’s state of being. Condition is also frequently referenced within engineering and 
manufacturing industries to describe the state or order in which a piece of equipment 
exists.8 In the field of sports medicine, condition is used within the context of training or 
acclimatizing a person physically,9 while in the field of law, condition is viewed as the 
essence of a contract.10 Recent literature explores the barriers of adapting condition-based 
maintenance to other industries (e.g. steel-making, chemical processing). Although 
condition-based maintenance has practical application within health care, no published 
literature could be found applying the concept to the monitoring of human health 
conditions. To gain a firm understanding of condition-based maintenance, the definitions 
of condition, based, and maintenance will be examined both independently and together. 
Condition. The Middle English noun condition is derived from the 14th century 
Old French term condicion, a derivative of the Latin condicio, meaning “terms of 
agreement.” Condition is defined as: 
• “a usually defective state of health” 
• “a way of living or existing” 
• “the state in which something exists: the physical state of something” 
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• “the physical or mental state of a person or animal” 
• “a premise upon which the fulfillment of an agreement depends” 11 
Based. According to Merriam-Webster, the word based was first known to be 
used in the 13th century. The adjective is Middle English, originally derived from the 
Greek bainein, meaning “to go.” Definitions include 
• “the bottom or lowest part of something: the part on which something 
rests or is supported” 
• “something (such as a group of people or things) that provides support for 
a place, business, etc.” 
• “a main ingredient to which other things are added to make something” 
• “the fundamental part of something”  
• “something on which something else is established” 12 
Maintenance.  Maintenance13 (noun) dates to the mid-14th century from an Old 
French term maintenir, meaning “action of providing a person with the necessities of 
life.” Definitions for the modern term include 
• “the combination of all technical and associated administrative actions 
intended to retain a system in a state in which it can perform its required 
function”14 
• “all technical and managerial actions taken during usage period to 
maintain or restore the required functionality of a product or an asset”15 
Condition-based maintenance. Condition-based maintenance, also known at the 
time as predictive maintenance, was first introduced by the Rio Grande Railway 
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Company in the late 1940s.4 Over time, slight variations of the definition have evolved 
and can be found throughout the literature: 
• “monitoring one or more indicators of asset condition that can be used to 
give warning of asset deterioration sufficiently in advance of failure so 
that there remains time to take preventive action”16 
• “a decision-making strategy where the decision to perform maintenance is 
reached by observing the condition of the system and/or its components”17 
• “a set of maintenance actions based on real-time or near real-time 
assessment of equipment condition, which is obtained from embedded 
sensors and/or external tests & measurements taken by portable 
equipment’18 
• “a maintenance policy which does maintenance actions before product 
failures happen, by assessing product condition including operating 
environments, and predicting the risk of product failures in a real-time 
way, based on gathered product data”15 
In this paper, condition-based maintenance is defined as an efficient, proactive 
process utilizing monitoring methods to predict, identify, and repair health-related 
problems precisely, therefore extending one’s life. 
Defining Attributes 
Walker and Avant7 describe attributes as the characteristics most often related 
with the concept, differentiating the concept from other associated concepts. Through the 
exploration of identified attributes, condition-based maintenance can then be 
distinguished from other types of maintenance. Four primary attributes were identified 
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following a review of the literature: predictive, proactive, precise, and efficient (Table 
2.1).  
Table 2.1 
Attributes of Condition-Based Maintenance 
Sources Number of Attributes Predictive Proactive Precise Efficient 
Abdul Rahman, et al., 2013 1 of 4 +    
Abou-El-Seoud & Matsui, 2014 3 of 4 + +  + 
Abou-El-Seoud, et al., 2012 3 of 4 +  + + 
Ahmad & Kamaruddin, 2012 2 of 4 +   + 
Altosole, et al., 2014 3 of 4 +  + + 
Baglee, et al., 2016 3 of 4 + +  + 
Baraldi, et al., 2013 1 of 4   +  
Bousdekis, et al., 2015 4 of 4 + + + + 
Byon, 2013 2 of 4   + + 
Byon, et al., 2011 1 of 4 +    
Corodón, et al., 2011 1 of 4 +    
de Jonge, et al., 2017 2 of 4 +  +  
Dong, et al.,2013 2 of 4 +  +  
Eker & Camci, 2013 2 of 4 +   + 
Feng, et al., 2015 1 of 4 +    
Grasso, et al., 2014 2 of 4 +   + 
Greenough & Grubic, 2011 1 of 4    + 
Guan, et al., 2013 2 of 4 +   + 
Guo, et al., 2016 2 of 4 +   + 
Huang, 2010 1 of 4 +    
Hussain, 2015 2 of 4   + + 
Jayaswal, et al., 2013 3 of 4 +  + + 
Jiang, et al., 2012 3 of 4 +  + + 
Kamei & Takai, 2011 1 of 4 +    
Khodabakhshian, 2013 3 of 4 + +  + 
Kisić, et al., 2015 3 of 4 +  + + 
Last, et al., 2011 2 of 4 +   + 
Lee & Ni, 2015 4 of 4 + + + + 
Lee, et al., 2014 1 of 4    + 
Lee, et al., 2015 2 of 4 +   + 
Li, et al., 2014 3 of 4 + +  + 
Li, et al., 2015 1 of 4    + 
Liu, et al., 2012 1 of 4   +  
Lubini & Fuamba, 2011 3 of 4 +  + + 
Meyer & Adams, 2013  1 of 4 +    
Naderkhani & Makis, 2015 2 of 4  +  + 
Pack, 2014 3 of 4 + +  + 
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Table 2.1 (continued) 
Sources Number of 
Attributes 
Predictive Proactive Precise Efficient 
Prajapati & Ganesan, 2013 3 of 4 +  + + 
Rasaienia, et al., 2013 2 of 4 +  +  
Safari, et al., 2010 2 of 4   + + 
Shin & Jun, 2015 4 of 4 + + + + 
Shinkai, et al., 2013 1 of 4    + 
Tarefder, et al., 2013 1 of 4 +    
Terpening, et al., 2016 3 of 4 +  + + 
Thompson, 2010 2 of 4 +  +  
Van & Bérenguer, 2012 2 of 4 +   + 
Van Dam & Bond, 2015 2 of 4 + +   
Wang, et al., 2014 1 of 4  +   
Wu, et al., 2013 2 of 4 +   + 
Xia, et al., 2011 2 of 4 +   + 
Xiang & Coit, 2014 2 of 4 +   + 
Xu, et al., 2012 1 of 4 +    
Yakub, et al., 2012 2 of 4 +  +  
Zhang, et al., 2010 4 of 4 + + + + 
Zhou, et al., 2014 2 of 4 +   + 
Zhu, et al., 2015 1 of 4  +   
 
Predictive. Literature containing the use of predictive in relation to condition-
based maintenance defines the term in an analytical, prognostic fashion. Through 
application of condition-based maintenance, the end-user, or clinician, can gather 
monitored data, analyze the findings, and in turn predict future failures or life 
expectancy.19,20 Within health care, predictive models have been used for disease 
management considering they stratify risk and increase the optimization of clinical 
resource utilization. Several condition-based maintenance algorithms, or decision support 
systems, exist today to guide the end-user, or provider, in identifying appropriate 
responses related to data findings.21 With the ability to make informed decisions, 




Proactive. In a technologically savvy world, there are many opportunities to use 
or develop a proactive solution to identified problems. With the case of condition-based 
maintenance, having a monitoring process in place allows the end user to not only predict 
but also proactively repair deteriorating systems before they advance to a state of 
failure.21,24 For example, if predictive measures indicated an individual with congestive 
heart failure was deteriorating based on increased weight and shortness of breath, a 
provider could proactively intervene, preventing unnecessary stress for the individual and 
a potential visit to the emergency department.  
Precise. The success of condition-based maintenance lies in the ability of the 
concept to be precise in predicting deterioration. Just as an engineer intimately 
understands how a specific piece of equipment works, a provider should also have a 
complete understanding of the patient clinically to accurately set up predictive measures 
and precise treatment should deterioration occur.25  
Efficient. The use of condition-based information has fewer associated costs than 
other concepts that do not monitor deterioration.25 In contrast to planned maintenance 
models, where maintenance is performed based upon predefined scheduled intervals, 
condition-based maintenance is performed only when deterioration is detected.26 
Condition-based maintenance lengthens the span of time between repairs, or office visits, 
reducing unnecessary maintenance activities that cost time, money, and manpower. 
Currently, health care in the United States most closely resembles the structure of a 
planned maintenance model, where patients are scheduled for predetermined office visits. 
From infancy through adulthood, preventative care recommendations are made outlining 
when patients should see their providers and undergo certain tests and procedures. While 
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these recommendations are largely evidence-based, the goal of catching disease through 
predetermined screening activities may be costlier in cases where only a very small 
fraction of the population will become ill in the absence of preventive measures. 
Constructed Cases 
Model case. Mrs. Jones is an 81-year-old female who had an aortic valve repair 
(AVR) six days ago. Today’s labs revealed a hemoglobin and hematocrit of 11/29 
respectively and her cardiac echogram ejection fraction was 36%, previously 32% during 
surgery. Mrs. Jones was started on 20mg furosemide daily and weekly erythropoietin 
injections (predictive). As she prepared for discharge, she received verbal instructions 
from both her primary nurse and cardiac surgeon. In addition to the printed discharge 
materials, Mrs. Jones was provided an SpO2 monitor (monitor and analyze deterioration 
data) and explicit instructions for use with successful return demonstration (proactive). 
Four days after Mrs. Jones was discharged home from the hospital, she notices a weight 
gain of five pounds and her SpO2 monitor is reading 94%, down from her usual 98% 
(abnormal data values). Throughout the day, Mrs. Jones’ legs feel noticeably “heavier” 
and she experiences difficulty catching her breath when walking. That afternoon, her 
daughter visits for lunch, listens to her mother’s concerns, notes the symptoms she is 
having, and rechecks her SpO2 that reads 93%. Mrs. Jones’ daughter assists her in calling 
her primary care provider. The physician asks specific questions related to her cardiac 
function then instructs Mrs. Jones to take an additional 20mg of furosemide each day and 
calls in a prescription for an angiotensin-converting-enzyme inhibitor (ACEI; precise & 
efficient). The following morning, Mrs. Jones notes a weight loss of two pounds and a 
decrease in her shortness of breath and leg swelling. Mrs. Jones is able to reduce her 
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clinic visits and stay out of the hospital due to the at-home monitoring process set in 
place (increased safety; decrease burden and costs). Mrs. Jones’ health is stable and she 
is able to enjoy life with her family and friends (life extension).   
This scenario is a model case because it includes all four critical attributes and 
exemplifies the identified definition of condition-based monitoring. The provider predicts 
the patient may have complications following surgery based on objective data gathered in 
the hospital. This prompts the provider to proactively set up a process through which the 
patient can be monitored for signs of deterioration long before a crisis occurs. When the 
patient begins deteriorating, the provider asks precise questions and responds with a 
precise and efficient treatment to meet the needs of the patient. Overall, this process is 
efficient; it was handled quickly over the phone and kept the patient from deteriorating 
further and needing an appointment, or worse, re-hospitalization. 
Borderline case. Claire is a type II diabetic who used the last of her long-acting 
insulin this morning. Claire placed a call to her primary care provider and left a voicemail 
requesting renewal of her prescription (precise). Mid-morning, her primary care provider 
calls in the prescription to Claire’s identified pharmacy on file then calls Claire to close 
the loop and notify her the prescription has been placed (efficient).   
In this borderline case, only two of the four attributes are represented. Claire has a 
chronic condition she is being treated for and could have predicted her need for additional 
insulin. Indeed, Claire could have proactively reached out to her primary care provider 
before running out of insulin to prevent a potential health crisis.  
Contrary case. Jed wakes up feeling as though he is coming down with a cold. 
The next day he is short of breath, diaphoretic, and has an increased work of breathing. 
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Jed’s wife drives him to the local emergency department, where he is admitted. After 
multiple tests and procedures, Jed is diagnosed with congestive heart failure. 
This is a contrary case, as it does not contain any of the attributes associated with 
the concept. Jed became acutely ill to where he could not predict or proactively treat. Due 
to his various symptoms, emergency department providers ordered multiples tests and 
procedures related to their constructed dual diagnoses. This episode of health care 
delivery, while appropriate, was neither precise nor efficient. 
Antecedents 
The conditions and events that precede a concept are labeled antecedents.7 In 
relation to condition-based maintenance, two antecedents have been identified in the 
literature: monitor and analyze deterioration data, and abnormal data values (Figure 
2.2).15,16 
 
Figure 2.2. Antecedents, defining attributes, and consequences of condition-based 
maintenance. 
 














A structure and process must be in place to monitor and analyze data to detect 
deterioration. Monitored data points can then be gathered and analyzed to better predict 
whether or not deterioration is detected. Deterioration is identified through abnormal 
values and predicts not only whether a maintenance intervention is required to 
proactively prevent an episode of failure, but also estimated life expectancy.17 
Consequences 
Subsequent events that occur as a result of the concept are labeled consequences.7 
Throughout the literature, three positive consequences are consistently identified as a 
result of condition-based maintenance: life extension, decreased burden and costs, and 
increased safety.   
Asset life may be extended with the use of condition-based maintenance because 
it essentially prevents failure from occurring. As a result, there is both better utilization of 
the asset’s life and a reduction in maintenance cost.25 Application of condition-based 
maintenance also leads to a decrease in burden and costs.27 As data are gathered from the 
monitoring process, early indication of deterioration can be identified and proactive, and 
precise maintenance can then be performed. Safety is increased when an asset is 
identified as deteriorating and proactive and precise maintenance is performed to prevent 
failure.26   
Empirical Referents 
The attributes of condition-based maintenance—predictive, proactive, precise, 
and efficient—can be measured quantitatively. In reviewing the literature, several 
instruments were identified (e.g., the electronic vibration measurement instrument).28 
Unfortunately, all identified instruments are specific to the monitoring of equipment and 
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are not transferrable to monitoring human conditions. Considering the attributes along 
with the antecedents and consequences, there are a number of ways to create applicable 
instruments within the health care industry. Instrument construction must be disease 
specific since the monitoring and analyzing of deterioration data would be unique to 
specific diseases.   
Discussion 
This analysis emphasizes the importance of symptom science through the 
transposing and trialing of established monitoring methods to improve patient safety, 
increase life-span, and decrease burden and health care costs. This concept analysis is 
considered innovative; nonetheless, it is also abstract in nature. Without applicable 
empirical referents, further research is needed to identify if condition-based maintenance 
can be adapted to monitoring various human conditions effectively. Additional 
quantitative and qualitative research focusing on both disease-specific measurements and 
quality of life components could further develop the concept in becoming more concrete. 
Outcomes from this analysis may be useful in the development and testing of 
measurement instruments. 
Relevance to Clinical Practice 
Condition-based maintenance advances the NINR’s29 focus on “developing 
personalized strategies to treat and prevent the adverse symptoms of illness across diverse 
populations and settings.” Clarifying the concept of condition-based maintenance may 
lead to improved assessment practices through early identification of symptom 
precursors, optimization of symptom dynamics, and prevention of symptom relapse or 
clinical deterioration.   
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In this concept analysis, condition-based monitoring is explored and defined 
within the context of the health care industry to further advance symptom science efforts. 
An abundance of literature on condition-based monitoring exists; however, research 
focusing on the application of the concept within health care is limited. Through the 
identification of antecedents, attributes, and consequences, health care providers may 
begin to investigate the translation of this concept into clinical practice. Constructed 
cases demonstrating the presence and absence of the attributes are provided to enhance 
the understanding of condition-based monitoring as a concept. Empirical referents are 
proposed to enhance recognition of this abstract concept and measure defining attributes 
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Background: Anemia is linked to structural and functional cardiac dysfunction. As 
patients become burdened with symptoms, they are more likely to be referred to a 
cardiothoracic surgeon for structural repair of the heart. 
Objective: The purpose of this study was to describe the relationship between 
preoperative anemia and 30-day hospital readmission among adult postoperative open-
heart patients.  
Methods: A retrospective, cross-sectional study was conducted using the Society of 
Thoracic Surgeons National Database for Adult Cardiac Surgery to identify 1,353 
surgical cases between August 2014 and July 2018. Descriptive, bivariate, and inferential 
statistics were used to describe the sample, examine relationships between variables, and 
identify the overall prevalence of anemia. Binomial logistic regression was used to assess 
the association with 30-day hospital readmission with preoperative anemia and 
sociodemographics.  
Results: Among the 1,353 open-heart surgery cases, approximately three quarters were 
male (n = 964, 71.2%); prevalence indicated 762 (56.3%) had no anemia, 373 (27.6%) 
had mild anemia, 210 (15.5%) had moderate anemia, 8 (0.6%) had severe anemia, and 
177 (13.5%) were readmitted to the hospital within 30 days of discharge. Preoperative 
anemia (Fisher’s χ2 = 21.3, p < .001) was significantly associated with 30-day hospital 
readmission. Logistic regression indicated that patients with severe preoperative anemia 
were 14.29 (95% CI 1.21, 167.9) times more likely to be readmitted to the hospital within 
30 days of discharge.  
Discussion: The findings from this study suggest severe preoperative anemia is 
associated with increased risk for 30-day hospital readmission. These results provide a 
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basis for further risk reduction strategies and preoperative optimization. Guidelines 
should be reviewed to include treatment of preoperative anemia and evaluation of reverse 
cardiac remodeling for prognosis. 
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Preoperative Anemia and 30-Day Hospital Readmission Among Adult Postoperative 
Open-Heart Patients: A Multisite Cross-Sectional Descriptive Study 
Introduction 
Preoperative anemia is a common yet modifiable preoperative finding associated 
with adverse perioperative and postoperative events, increased 30-day morbidity, and 
mortality (Burton et al., 2018; Burton et al., 2019; Dai et al., 2018; Jabagi et al., 2018; 
Karkouti, Wijeysundera, & Beattie, 2008; Nuis et al., 2013). Studies suggest the 
prevalence of preoperative anemia in patients undergoing cardiac surgery is higher than 
most surgeries, ranging from 13% to 67% (Dai, et al., 2018; Hubert et al., 2019; Karkouti 
et al., 2008; Kulier et al., 2007; Musallam et al., 2011; Nuis et al., 2013). In the United 
States, octogenarians hold the highest prevalence of anemia (19.4%) and moderate-severe 
anemia (4.0%), with up to 41% diagnosed with anemia in preoperative cardiac surgery 
cases (Carrascal et al., 2010; Le, 2016). Considering octogenarians make up 
approximately 8% of cardiac surgery cases and are increasingly being referred, it is 
imperative to take anemia into consideration during the preoperative assessment (Wang 
et al., 2014).   
The impact of preoperative anemia on morbidity and mortality has been well 
documented in the general surgery population. Patients with preoperative anemia are 
more likely to have lengthy hospitalizations and increased ventilatory days and are more 
likely to receive allogenic transfusions, each of which is associated with an increased risk 
of morbidity and mortality (Najafi & Faraoni, 2015; Ranucci et al., 2012; Shander, 
Knight, Thurer, Adamson, & Spence, 2004). Patients presenting with severe preoperative 
anemia have an expected mortality rate of 14% (Ranucci et al., 2012). Nonetheless, little 
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is known about the association between preoperative anemia in open-heart surgery 
patients on 30-day hospital readmission. The purpose of this multi-center cross-sectional 
study was to retrospectively examine the relationship between preoperative anemia 
(hemoglobin, hb < 13g/dL) and 30-day hospital readmission among adult postoperative 
open-heart patients. The specific aims were: 
• Aim 1: Estimate the prevalence of preoperative anemia among adults seeking 
urgent or elective open-heart surgery. 
• Aim 2: Examine the relationship between preoperative anemia, 
sociodemographics, and 30-day hospital readmission rates among 
postoperative open-heart adult patients. 
Methods 
Study Design and Data Collection 
Study oversight was conducted by the institutional review boards of both the 
participating health care system and university. Retrospective data were extracted using 
the Society of Thoracic Surgeons (STS) National Database for Adult Cardiac Surgery. 
This reputable database is a prospective clinical outcomes registry designed to provide 
organizations and clinicians with benchmarked risk-adjusted outcomes (D’Agostino et 
al., 2018). With more than 30 years of data collection and 6.5 million record entries, 
researchers have and continue to develop meaningful quality and safety improvements in 
cardiac surgery worldwide (Badhwar et al., 2018). Registry data includes anonymized 
demographics, admission sources, preoperative risk factors, laboratory and medication 
data, perioperative variables, and postoperative outcomes for patients undergoing cardiac 
surgery. Data managers are trained by the STS through online modules and a mentorship 
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program. Data managers manually extract patient information from multiple sources 
using a standardized worksheet provided by the STS. Patient information is then 
transcribed from the worksheet into the registry via vendor software (STS, 2019). For this 
study, the investigator used data from August 2014 through July 2018 gathered from 
three southern California community hospitals. The initial extraction yielded 5,047 cases. 
Cases were subsequently removed from the sample if the patient had (a) a known prior 
CABG or valve-related procedure, (b) emergency surgery requiring immediate 
intervention, (c) concurrent atrial fibrillation procedure, (d) undergone a tricuspid or 
pulmonic valve procedure, (e) died during hospitalization, (f) preoperative diagnosis of 
cardiogenic shock, and (g) lacked a preoperative hemoglobin value. Following the 
exclusions, 1,353 cases with patient data for X number of variables were used for the 





Figure 3.1. Consort diagram. 
 
Procedures 
In 1968, the World Health Organization (2015) provided an operational definition 
of anemia as a hemoglobin < 13g/dL for males and < 12g/dL for non-pregnant females. 
For this study, preoperative anemia was defined as a hemoglobin concentration of less 
than 13g/dL for both men and women. Patients with anemia were further divided into 
three classes: mild anemia (hb 10.1-12.9 g/dL), moderate anemia (hb 8-10g/dL), and 
severe anemia (hb < 8g/dL; WHO, 2015). Preoperative anemia was identified by the last 
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hemoglobin measurement prior to the index operation. The postoperative outcome of 30-
day hospital readmission included all cause readmissions. 
Statistical Analysis 
Descriptive statistics were calculated for all variables and data were analyzed for 
normality, missing values, and outliers. Bivariate analyses (chi-square, Fisher’s exact, 
One-way between groups Analysis of Variance) were used to examine the relationships 
between patients’ sociodemographic characteristics, preoperative risk factors (including 
preoperative anemia), intraoperative factors, postoperative factors, and 30-day hospital 
readmission. Variables significant at p < .05 in the bivariate analysis were considered for 
entry in a multivariate logistic regression model to ascertain factors that increase the odds 
of 30-day hospital readmission among postoperative open-heart adult patients. Variables 
at p < .25 known to be of clinical importance based on the extant literature (Hannan et al., 
2011; Hernández-Leiva, Dennis, Isaza, & Umaña, 2013; Kassin et al., 2012; Merkow et 
al., 2015) were also considered for entry into the logistic regression model. A less 
traditional p level can help identify variables that by themselves are not significantly 
associated with the outcome but may play an important role in the presence of other 
variables (Bursac, Gauss, Williams, & Hosmer, 2008). A total of 34 out of over 80 
potential predictors were identified at the p < .25 level in the bivariate analysis. To 
evaluate the role of each variable considered for entry into the logistic regression model, 
multiple logistic regression models were run removing, one-by-one, those non-significant 
variables at p < .10 that were not confounders (Exp(B) < 20%). A change in the 
parameter estimate greater than 20% indicates the removed variable is important in that it 
provides an adjustment for one or more of the variables remaining in the model (Bursac 
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et al., 2008). After considering all 34 variables, the final two models included those 
variables that remained significant at the .05 level and additional variables that were not 
statistically significant but were considered a priori to be important determinants of 30-
day hospital readmission risk (Bursac et al., 2008; Hosmer & Lemeshow, 2000). All 
statistical analyses were carried out using IBM SPSS software version 25.0.  
Results 
Sociodemographic and clinical characteristics of study participants by anemia 
severity are presented in Tables 3.1 and 3.2; sociodemographic and clinical 
characteristics of study participants overall and by 30-day hospital readmission are 
presented in Tables 3.3 and 3.4. Among the 1,353 patients who underwent open-heart 
surgery, approximately three quarters were male (71.2%, n = 964), 44.1% (n = 573) were 
White, non-Hispanic, and 76.6% (n = 397) had Medicare as their primary insurance 
payor. Primary admission source was evenly distributed for elective admission (49%, n = 
663) and admission through the emergency department (44.1%, n = 597). Notable 
comorbidities included diabetes (47.3%, n = 640), dyslipidemia (86%, n = 1164), 
hypertension (87.1%, n = 1,177), and tobacco use (48.6%, n = 654). Seven-hundred and 
sixty-two (56.3%) patients had no anemia, 373 (27.6%) had mild anemia, 210 (15.5%) 
had moderate anemia, and 8 (0.6%) had severe anemia. Finally, 177 (13.5%) were 
readmitted to the hospital within 30-days after discharge.  
Preoperative Anemia 
Bivariate analyses (chi-square and Fisher’s exact tests for association) were 
conducted to evaluate the relationship between categorical variables and preoperative 
anemia severity (no anemia, mild anemia, moderate anemia, severe anemia) for 
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postoperative open-heart adult patients (Tables 3.1 and 3.2). A complete list of the 60 
categorical variables evaluated can be found in Appendix A. The level of significance 
was set to p < .05. There was a statistically significant difference between preoperative 
anemia severity and gender (χ2(3) = 116.25, p < .001, Cramer’s V = .293; small effect), 
zip code, race, hospital name, admission source, diabetes, dyslipidemia, hypertension, 
prior myocardial infarction, cardiac presentation, ADP inhibitors within 5-days, 
anticoagulants within 24-hours, surgery status (elective or urgent/emergent), urgent 
surgery reason, intraop blood products (χ2(3) = 162.44, p < .001, Cramer’s V = .339; 
moderate effect), intraop blood products: RBC units (χ2(3) = 226.18, p < .001, Cramer’s 
V = .330; moderate effect), intraop blood products: FFP units, intraop blood products: 
Platelet units, postop blood products, postop blood products: RBC units, postop blood 
products: FFP units, intraop Epsilon-aminocaproic acid, intraop Tranexamic acid, 
cardiopulmonary bypass utilization, mitral valve procedure, readmission to intensive care 
unit, postop renal impairment, postop other cardiac arrest, postop other atrial fibrillation, 




Sociodemographic Characteristics of Study Population by Severity of Preoperative Anemia (N = 1,353)  
  Preoperative Anemia Severitya   
 Total No Anemia Mild Moderate Severe   
Characteristic  n % n % n % n % n % χ2 p 
Gender           116.25 < .001 
Female 389 28.8 131 33.7 169 43.4   87 22.4 2 0.5   
Male 964 71.2 631 65.5 204 21.2 123 12.8 6 0.6   
Race           68.17 < .001b 
White, non-Hispanic 573 44.1 377 65.8 133 23.2   60 10.5 3 0.5   
Hispanic, Latino 358 27.6 163 45.5 104 29.1   87 24.3 4 1.1   
Black, African American   32   2.5   10 31.3   11 34.4   11 34.4 0 0.0   
Asian, Pacific Islander 146 11.2   71 48.6   52 35.6   23 15.8 0 0.0   
Other 189 14.6 101 53.4   64 33.9   23 12.2 1 0.5   
Zip Code           37.21 .024b 
San Diego Co.: Central 172 12.8   78 45.3   53 30.8   37 21.5 4 2.3   
San Diego Co.: East 448 33.4 248 55.4 126 28.1   72 16.1 2 2.7   
San Diego Co.: North Central 184 13.7 119 64.7   46 25.0   19 10.3 0 0.0   
San Diego Co.: North Coastal   21   1.6   14 66.7     6 28.6     1   4.8 0 0.0   
San Diego Co.: North Inland 102   7.6   72 70.6   19 18.6   10   9.8 1 1.0   
San Diego Co.: South County 332 24.7 179 53.9   96 28.9   56 16.9 1 0.3   
Out of Co.: East   37   2.8   18 48.6   14 37.8     5 13.5 0 0.0   
Out of Co.: North   33   2.5   19 57.6     9 27.3     5 15.2 0 0.0   
Out of State   13   1.0     8 61.5     3 23.1     2 15.4 0 0.0   
Hospital            40.98 < .001b 
Hospital A 334 24.7 155 46.4 107 32.0   69 20.7 3 0.9   
Hospital B 430 31.8 223 51.9 128 29.8   78 37.1 1 0.2   
Hospital C 589 43.5 384 65.2 138 23.4   63 10.7 4 07   
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Table 3.1 (continued) 
Note. BMI = Body Mass Index; Co. = County; F = One-Way ANOVA unless otherwise specified; M = Mean; SD = Standard Deviation; χ2 = Fisher’s 
Exact Test unless otherwise specified. aPreoperative Anemia Severity: No-anemia (hb ≥ 13 g/dL), mild anemia (hb 10.1-12.9 g/dL), moderate anemia 
(hb 8-10g/dL), and severe anemia (hb < 8g/dL). bMonte Carlo Sig. (2-sided). cWelch Sig. (2-sided).    
  Preoperative Anemia Severitya   
 Total No Anemia Mild Moderate Severe   
Characteristic  n % n % n % n % n % χ2 p 
Admission Source           72.74 < .001 
Elective admission 663 49.0 429 64.7 178 26.8   52 7.8 4 0.6   
Emergency department 597 44.1 289 48.4 171 28.6 135 22.6 2 0.3   
Transfer from hospital or acute 
care facility, or other admission 
source 
  93   6.9   44 47.3   24 25.8   23 24.7 2 2.2   
 M SD M SD M SD M SD M SD F p 
Age 64.16 11.00 62.99 10.49 66.24 10.63 64.87 12.64 59.63 13.07 8.13 < .001c 
BMI 28.86   5.83 29.32 5.66 28.98 6.32 27.08 5.17 27.33 6.37 9.78 < .001c 
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One-way between groups Analysis of Variance (ANOVA) was conducted 
between continuous variables and preoperative anemia severity (no-anemia, mild anemia, 
moderate anemia, severe anemia) for postoperative open-heart adult patients (Tables 3.1 
and 3.2). Significance was established at p < .05. A complete list of the 23 continuous 
variables evaluated can be found in Appendix A. Homogeneity of variances was assessed 
by Levene's test of homogeneity of variances; Welch robust test for equality of means are 
reported for those ANOVA results that do not meet the homogeneity of variance 
assumption. There was a statistically significant difference between preoperative anemia 
severity based on age (p < .001), BMI (p < .001), hemoglobin (p < .001), preop creatinine 
(p < .001), preop albumin (p < .001), preop A1c (p = .001), Hemo Data-EF (p = .004), 
intraop packed red blood cells (p < .001), intraop platelets (p = .003), postop creatinine (p 
< .001), postop hemoglobin (p < .001), initial ICU hours (p < .001), total OR hours (p = 
.006), admission to discharge LOS (days, p < .001), surgery to discharge LOS (days, p = 
.006), and total ICU hours (p < .001). 
Pre-operative hemoglobin levels were significantly different for patients in terms 
of their anemia levels (Welch's F[3, 34] = 179. 54, p < .001). Pre-operative hemoglobin 
levels decreased from the no anemia (M = 14.40, SD = 0.99), mild anemia (M = 12.05, 
SD = 0.58), moderate anemia (M = 9.80, SD = 0.81), and the severe anemia (M = 7.26, 
SD = 1.07) groups. Games-Howell post-hoc analysis revealed the decrease in pre-
operative hemoglobin levels from the no anemia to the mild anemia groups (2.22, 95% CI 
2.22 to 2.46, p < .001), from the mild to the moderate anemia groups (2.26, 95% CI 1.29 
to 2.42, p < .001), and from the moderate to the severe anemia groups (2.54, 95% CI 1.29 





Clinical Characteristics of Study Population by Severity of Preoperative Anemia (N = 1,353) 
  Preoperative Anemia Severitya   
 Total No Anemia Mild Moderate Severe   
Characteristic  n % n % n % n % n % χ2 p 
Diabetes           58.82 < .001 
Yes   713 52.7 292 45.6 212 33.1 130 20.3 6 0.9   
No   640 47.3 470 65.9 161 22.6   80 11.2 2 0.3   
Dyslipidemia           9.01 .024 
Yes 1164 86.0 651 55.9 335 28.8 172 14.8 6 0.5   
No   189 14.0 111 58.7   38 20.1   38 20.1 2 1.1   
Hypertension           23.48 < .001 
Yes 1177 87.1 637 54.1 347 29.5 187 15.9 6 0.5   
No   175 12.9 125 71.4   26 14.9   22 12.6 2 1.1   
Prior Myocardial Infarction           15.09 .001 
Yes   553 40.9 279 50.5 166 30.0 103 18.6 5 0.9   
No   800 59.1 483 60.4 207 25.9 107 13.4 3 0.4   
Cardiac Presentation Symptoms           35.50 .004b 
Angina equivalent     41   3.0   24 58.5   10 24.4     7 17.1 0 0.0   
No symptoms     90   6.7    50 55.6   24 26.7   15 16.7 1 1.1   
Non-ST elevation MI   280 20.7 134 47.9   81 28.9   63 22.5 2 0.7   
ST elevation MI     39   2.9   19 48.7   12 30.8     8 20.5 0 0.0   
Stable angina     73   5.4   47 64.4   23 31.5     3 4.1 0 0.0   
Unstable angina   381 28.2 224 58.8 115 30.2   40 10.5 2 0.5   
Other   448 33.1 264 58.9 107 23.9   74 16.5 3 0.7   
ADP Inhibitors Within 5 Days           8.36 .034 
Yes     63   4.7   26 41.3   21 33.3   15 23.8 1 1.6   
No 1289 95.3 736 57.1 351 27.2 195 15.1 7 0.5   
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Table 3.2 (continued) 
  Preoperative Anemia Severitya   
 Total No Anemia Mild Moderate Severe   
Characteristic  n % n % n % n % n % χ2 p 
Anticoagulants Within 48 Hours           32.57 < .001 
Yes   527 39.0 255   48.4 154 29.2 112 21.3 6 1.1   
No   826 61.0 507   61.4 219 26.5   98 11.9 2 0.2   
Surgery Status           59.64 < .001 
Elective   477 35.3 326   68.3 115 24.1   36   7.5 0 0.0   
Urgent or emergent reason   876 64.7 436   49.8 258 29.5 174 19.1 8 0.9   
Urgent Surgery Reason           76.45 < .001b 
AMI; ongoing ischemia; USA; 
worsening CP; rest angina; 
syncope 
  357 40.8 181   50.7   98 27.5   76 21.3 2 0.6   
Anatomy, intra cardiac mass 
or thrombus, valve dysfunction   130 14.9   77   59.2   32 24.6   19 14.6 2 1.5   
Angiographic accident, 
diagnostic/ interventional 
procedure complication; PCI 
incomplete without clinical 
deterioration 
      1   0.1     1 100.0     0   0.0     0   0.0 0 0.0   
Aortic aneurysm, aortic 
dissection     12   1.4     5   41.7     6 50.0     1   8.3 0 0.0   
CHF, pulmonary edema   109 12.5   45   41.3   38 34.9   25 22.9 1 0.9   
Trauma, other   234 26.8 125   53.4   78 33.3   30 12.8 1 0.4   
Endocarditis     31   3.5     2     6.5     5 16.1   22 71.0 2 6.5   
Intraop Blood Products           162.44 < .001 
Yes   673 50.0   281   41.8   211 31.4 174 25.9 7 1.0   
No   672 50.0   476   70.8   160 23.8   35   5.2 1 0.1   
Intraop Epsilon Aminocaproic 
Acid           16.66 .001 
Yes 1041 76.9   614 59.0 279 26.8 142 13.6 6 0.6   
No   312 23.1   148 47.4   94 30.1   68 21.8 2 0.6   
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Table 3.2 (continued) 
 
   Preoperative Anemia Severitya   
 Total No Anemia Mild Moderate Severe   
Characteristic n % n % n % n % n % χ2 p 
Intraop Tranexamic Acid           9.27 .022 
Yes   213 15.7   104 48.8   61 28.6   47 22.1 1 0.5   
No 1140 84.3   658 57.7 312 27.4 163 14.3 7 0.6   
Cardiopulmonary Bypass           14.22 .024 
No   214 17.8 116 48.1   81 33.6   43 17.8 1 0.4   
Full 1107 81.8 645 58.3 290 26.2 165 14.9 7 0.6   
Combination        5   0.4     1 20.0     2 40.0     2 40.0 0 0.0   
Valve Procedure: Mitral           7.64 .022 
Repair, reconstruction   139 63.2   85 61.2   28 20.1   26 18.7 0 0.0   
Replacement     81 36.8   34 42.0   25 30.9   22 27.2 0 0.0   
Readmission into ICU           9.13 .026 
Yes     41   3.0   17 41.5   11 26.8   12 29.3 1 2.4   
No 1312 97.0 745 56.8 362 27.6 198 15.1 7 0.5   
Postop Sternal-Superficial 
Infection           9.32 .007 
Yes, within 30 days of 
procedure     11 28.9     9 81.8     1   9.1     1   9.1 0 0.0   
No     27 71.1     7 25.9   13 48.1     7 25.9 0 0.0   
Postop Renal Impairment           15.40 .001 
Yes     41   6.3   11 26.8   16 39.0   13 31.7 1 2.4   
No   615 93.8 364 56.3 162 26.3 101 16.4 6 1.0   
Postop Dialysis After Discharge           7.60 .041 
Yes       9 45.0     0   0.0     3 33.3     5 55.6 1 11.1   
No     11 55.0     6 54.5     2 18.2     3 27.3 0 0.0   
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Table 3.2 (continued) 
   Preoperative Anemia Severity   
 Total No Anemia Mild Moderate Severe   
Characteristic  n % n % n % n % n % χ2 p 
Postop Other Cardiac Arrest           13.0 .004 
Yes     25   3.8 357 54.4 178 27.1 114 17.4 7 1.1   
No   631 96.2 350 55.5 168 26.6 108 17.1 5 0.8   
Postop Other A Fib           24.97 < .001 
Yes   443 67.5 265 59.8 115 26.0   62 14.0 1 0.2   
No   213 32.5   92 43.2   63 29.6   52 24.4 6 2.8   
Discharge Location           96.61 < .001b 
Extended care, transitional 
care unit   224 16.6   70   31.3   88 39.3   64   28.6 2 0.9   
Home 1108 82.0 685   61.8 277 25.0 140   12.6 6 0.5   
Nursing home       9   0.7     2   22.2     4 44.4     3   33.3 0 0.0   
Other acute care hospital        9   0.7     3   33.3     4 44.4     2   22.2 0 0.0   
Left against medical advice       1   0.1     0     0.0     0   0.0     1 100.0 0 0.0   
Other       1   0.1     1 100.0     0   0.0     0     0.0 0 0.0   
 M SD M SD M SD M SD M SD F p 
Preop Hemoglobin 13.00 1.97 14.40 0.99 12.05 0.58 9.80 0.81 7.26 1.07 1788.54 < .001c 
Preop Creatinine 1.23 1.24 0.97 0.39 1.16 0.97 2.22 2.44 2.73 3.62 21.39 < .001c 
Preop Total Albumin 3.83 0.52 4.00 0.44 3.77 0.46 3.37 0.53 3.17 0.98 80.88 < .001c 
Preop A1c Level  6.48 1.54 6.32 1.40 6.69 1.67 6.71 1.67 7.15 2.93 6.02   .003c 
Hemo Data EF 54.57 13.37 55.67 12.81 54.26 13.59 51.31 14.52 50.85 9.30 5.38   .004c 
Intraop Packed Red Blood Cells 2.20 2.35 1.34 1.79 2.42 2.19 3.19 2.71 5.86 2.67 33.50 < .001 
Intraop Platelet 1.59 2.05 1.93 1.77 1.41 2.22 1.28 2.19 1.14 1.68 4.65    .003 
Postop Creatinine 1.57 1.50 1.19 0.67 1.58 1.32 2.86 2.62 3.41 4.11 35.54 < .001c 
Postop Hemoglobin 9.91 1.39 10.32 1.39 9.51 1.19 9.12 1.15 8.1 0.00 8.52 < .001 
Initial ICU Hours 80.54 123.44 66.46 75.66 88.39 163.81 110.55 137.01 270.16 173.37 8.22 < .001c 
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Table 3.2 (continued) 
Note. BMI = Body Mass Index; EF = Ejection Fraction; ICU = Intensive Care Unit; LOS = Length of Stay; M = Mean; SD = Standard Deviation; OR = 
Operation Room; χ2 = Fisher’s Exact Test unless otherwise specified. aPreoperative Anemia Severity: No-anemia (hb ≥ 13 g/dL), mild anemia (hb 10.1-
12.9 g/dL), moderate anemia (hb 8-10g/dL), and severe anemia (hb < 8g/dL). bMonte Carlo Sig. (2-sided). cWelch Sig. (2-sided). 
 
 M SD M SD M SD M SD M SD F p 
Total OR Time 6.22 1.70 6.10 1.80 6.29 1.53 6.53 1.60 6.71 1.50 4.14    .006 
Admission to Discharge LOS 
(days) 14.93 14.21 12.41 10.64 15.07 10.88 21.47 11.45 34.14 27.53 9.16 < .001
c 
Surgery to Discharge LOS 
(days) 11.43 10.30 10.16 9.69 11.78 9.26 14.05 11.51 25.71 24.73 5.08   .006
c 
Total ICU Hours 86.27 139.83 70.89 96.50 93.49 173.58 122.06 165.38 276.80 487.30 7.45   .001c 
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30-Day Hospital Readmission 
Bivariate analyses (chi-square and Fisher’s exact tests for association) were 
conducted to evaluate the relationship between categorical variables and 30-day hospital 
readmission for postoperative open-heart adult patients; independent-samples t-tests were 
conducted between continuous variables and 30-day hospital readmission (Tables 3.3 and 
3.4). A complete list of the 60 categorical and 23 continuous variables evaluated can be 
found in Appendix A. The level of significance for all bivariate analyses was set to p < 
.05.  
There was a statistically significant difference between 30-day hospital 
readmission and: hospital name (Fisher’s χ2(2) = 25.02, p < .001, Cramer’s V = .136; 
small effect); admission source (Fisher’s χ2(3) = 27.92, p < .001, Cramer’s V = .145; 
small effect); diabetes (Fisher’s χ2(1) = 6.33, p = .012, Phi = .069; small effect); 
hypertension (Fisher’s χ2(1) = 5.94, p = .016, Phi = .067; small effect); tobacco use 
(Fisher’s χ2(1) = 13.71, p < .001, Phi = .102; small effect); preop anemia severity 
(Fisher’s χ2(3) = 21.34, p < .001, Cramer's V = .130; small effect); preop anemia yes/no 
(Fisher’s χ2(1) = 15.13, p < .001, Phi = .107; small effect); cardiac presentation 
symptoms (χ2(6) = 13.20, p = .037, Cramer’s V = .102; small effect), valve procedure 
yes/no (Fisher’s χ2(1) = 10.35, p = .001, Phi = -.089; small effect), and postop Intra-
Aortic Balloon Pump (Fisher’s χ2(1) = 16.37, p < .001, Phi = .112; small effect; Tables 
3.1 and 3.2). 
Independent samples t-tests indicated patients who were readmitted within 30 
days of hospital discharge had lower preop hemoglobin levels (M = 12.32, SD = 2.07) 
than those who were not readmitted (M = 13.09, SD = 1.94), a statistically significant 
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difference of 0.77 (95% CI, 0.46 to 1.08, t[1313] = 4.845, p < .001); patients readmitted 
also had lower preop total albumin levels (M = 3.67, SD = 0.56) than those who were not 
readmitted (M = 3.86, SD = 0.51), a statistically significant difference of 0.19 (95% CI, 
0.10 to 0.27, t[1190] = 4.362, p < .001). Furthermore, patients who were readmitted 
within 30 days of hospital discharge had higher preop creatinine levels (M = 1.53, SD = 
1.66) than those who were not readmitted (M = 1.15, SD = 1.25), a statistically significant 
difference of 0.38 (95% CI, -0.69.46 to -0.07, t[328] = -2.439, p = .015). Patients 
readmitted also had higher preop A1c levels (M = 6.86, SD = 1.91) than those who were 
not readmitted (M = 6.42, SD = 1.40), a statistically significant difference of 0.44 (95% 
CI, -0.80 to -0.08, t[302] = -2.394, p = .017), and patients readmitted had higher postop 
creatinine levels (M = 2.08, SD = 1.96) than those who were not readmitted (M = 1.36, 
SD = 1.00), a statistically significant difference of -0.73 (95% CI, -1.05 to -0.40, t[263] = 
-4.407, p > .001).  
Independent samples t-tests also revealed that patients who were readmitted 
within 30 days of hospital discharge stayed longer at the ICU initially and overall, had 
longer operation times, and had longer stays at the hospital (admission to discharge) than 




Sociodemographic Characteristics of Study Population by 30-Day Hospital Readmission (N = 1,353) 
Note. BMI = Body Mass Index; M = Mean; SD = Standard Deviation; χ2 = Fisher’s Exact Test unless otherwise specified. a30-Day Hospital 
Readmission = Any hospital readmission within the first 30-days after hospital discharge. bWelch Sig. (2-sided). 
 
  30-Day Hospital Readmissiona    
 Total Yes No   
Characteristic  n % n % n % χ2 p 
Gender       0.28   .593 
Female 389 28.8   54 14.2 325 85.8   
Male 946 71.2 123 13.1 813 86.9   
Race       2.35   .672 
White, non-Hispanic 573 44.1   78 13.9 483 86.1   
Hispanic, Latino 358 27.6   45 12.9 304 87.1   
Black, African American   32   2.5     6 19.4   25 80.6   
Asian, Pacific Islander 146 11.2   16 11.2 127 88.8   
Other 189 14.6   27 15.3 150 84.7   
Hospital          
Hospital A 334 24.7   53 16.3 273 83.7 25.02 <.001 
Hospital B 430 31.8   75 18.6 329 81.4   
Hospital C 589 43.5   49   8.4 536 91.6   
Admission Source       27.18 < .001 
Elective admission 663 49.0   56   8.6 596 91.4   
Emergency department 597 44.1 106 18.5 466 81.5   
Transfer from hospital or acute care 
facility, or other admission source 
  93   6.9   15 16.5   76 83.5   
 M SD M SD M SD t p 
Age 64.16 11.00 65.31 11.03 64.05 10.89 - 1.43   .154 




Clinical Characteristics of Study Population by 30-Day Hospital Readmission (N = 1,353) 
 
  30-Day Hospital Readmissiona    
 Total Yes No   
Characteristic  n % n % n % χ2 p 
Diabetes         6.33   .012 
Yes   640 47.3   99 55.9   521 45.8   
No   713 52.7   78 44.1   617 54.2   
Hypertension         5.94   .007 
Yes 1177 87.1 163 92.6   978 85.9   
No   175 12.9   13   7.4   160 14.1   
Tobacco Use       13.71 < .001 
Yes   654 48.3 108 61.0   521 46.1   
No   692 51.1   69 39.0   610 53.9   
Preoperative Anemia       21.34 < .001 
No-anemia   762 56.3   76 42.9   666 58.5   
Mild anemia   373 27.6   53 29.9   307 27.0   
Moderate anemia   210 15.5   46 26.0   159 14.0   
Severe anemia       8   0.6     2   1.1       6   0.5   
Preoperative Anemia       15.13 < .001 
No-anemia   762 56.3   76 42.9   666 58.5   
Anemia 591 43.7 101 57.1 472 41.5   
Cardiac presentation symptoms       13.20   .037b 
Angina equivalent     41   3.0     6   3.4     31   2.7   
No symptoms     90   6.7   11   6.8     77   6.2   
Non-ST elevation MI   280 20.7   53 29.9   217 19.1   
ST elevation MI     39   2.9     7   2.6     29   4.0   
Stable angina     73   5.4     8   5.5     63   4.5   
Unstable angina   381 28.2   43 24.3   328 28.8   
Other   448 33.1   49 27.7   392 34.5   
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Table 3.4 (continued) 
  
   30-Day Hospital Readmissiona   
 Total Yes No   
Characteristic  n % n % n % χ2 p 
Urgent Surgery Reason         9.83   .120 
AMI; ongoing ischemia; USA; worsening 
CP; rest angina; syncope 
  357 40.8   64 46.4   280 39.8   
Anatomy, intra cardiac mass or thrombus, 
valve dysfunction 
  130 14.9   25 18.1     99 14.1   
Angiographic accident, 
diagnostic/interventional procedure 
complication; PCI incomplete without 
clinical deterioration 
      1   0.1     1   0.7       0   0.0   
Aortic aneurysm, aortic dissection     12   1.4     1   0.7     11   1.6   
CHF, pulmonary edema   109 12.5   14 10.1     91 12.9   
Trauma, other   234 26.8   28 20.3   197 28.0   
Endocarditis     31   3.5     5   3.6     26   3.7   
Valve       10.35   .001 
Yes   554 40.9   54 30.5   493 43.3   
No   799 59.1 645 56.7   123 69.5   
Postop Intra-Aortic Balloon Pump       16.37 < .001 
Yes   138 10.2   33 18.6   100   8.8   
No 1215 89.8 144 81.4 1038 91.2   
Postop Renal Impairment         1.71   .252 
Yes     41   6.3    9   9.0     30   5.6   
No   615 93.8   91 91.0   507 94.4   
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Table 3.4 (continued) 
Note. BMI = Body Mass Index; M = Mean; SD = Standard Deviation; χ2 = Fisher’s Exact Test unless otherwise specified. a30-Day Hospital 
Readmission = Any hospital readmission within the first 30-days after hospital discharge. bMonte Carlo. 
 
 M SD M SD M SD t p 
Preop Hemoglobin 13.00   1.97 12.32   2.07   13.09   1.94   4.85 < .001 
Preop Creatinine   1.23   1.24   1.53   1.66     1.15   1.25 - 2.44    .015 
Preop total Albumin   3.83   0.52   3.67   0.56     3.86   0.51   4.36 < .000 
Preop A1c   6.48   1.54   6.86   1.91     6.42   1.40 - 2.39    .017 
Hemo Data EF 54.57 13.37 50.74 14.64   55.44 12.45   3.19    .002 
   30-Day Hospital Readmissiona   
 Total Yes No   
Characteristic M SD M SD M SD t p 
Postop Creatinine        1.57     1.50     2.08     1.96 1.36     1.00 - 4.41 < .001 
Initial ICU Hours     80.54 123.43   98.08 121.30 78.11 125.08 -1.98    .048 
Total OR Time       6.22     1.70     6.50     1.52   6.18     1.74 -2.35    .019 
Admission to Discharge LOS (days)     14.93   14.21   17.78   16.05 14.36   13.89 -2.33    .020 
Total ICU Hours 2722.00 139.83 113.90 163.49 75.98 122.72 - 2.47    .014 
 67 
 
Multiple Predictors of 30-Day Hospital Readmission  
A binomial logistic regression analysis was conducted to examine the effects of 
sociodemographic characteristics (gender, hospital admission source), preoperative risk 
factors (diabetes, hypertension, tobacco use, preoperative anemia, last creatinine, total 
albumin, and Ac1 level, cardiac presentation at admission, reason for surgery), 
intraoperative factors (surgery type), and postoperative factors (peak glucose level, 
postop IABP, renal impairment) on the likelihood that adult postoperative open-heart 
patients are readmitted to the hospital within 30 days of discharge. Linearity of the 
continuous variables with respect to the logit of the dependent variable was assessed via 
the Box-Tidwell (1962) procedure. All continuous independent variables were found to 
be linearly related to the logit of the dependent variable. The logistic regression model 
was also statistically significant (χ2[27] = 68.61, p < .001). The model explained between 
17.9% (Cox & Snell R2) and 28.1% (Nagelkerke R2) of the variance in hospital 
readmission and correctly classified 96% of cases. Sensitivity was 25.4%, specificity was 
96%, positive predictive value was 62.07%, and negative predictive value was 83.4%. 
Seven of the 15 predictor variables were statistically significant: (a) hospital admission 
source, (b) hypertension, (c) tobacco use, (d) preoperative anemia, (e) cardiac 
presentation at admission, (f) reason for urgent or emergent surgery, and (g) IABP. When 
compared to patients with an elective admission to the hospital, those admitted to the 
hospital through the emergency department were 7.35 times (95% CI 2.17, 24.9) more 
likely to be readmitted to the hospital in the first 30 days after hospital discharge; those 
transferred from another hospital, acute care facility, or any other facility were 7.96 times 
(95% CI 1.88, 33.66) more likely to be readmitted. Patients with hypertension were 9.5 
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times (95% CI 1.77, 51) more likely to be readmitted. Patients who used tobacco 
products were 2.71 times (95% CI 1.45, 5.08) more likely to be readmitted. When 
compared to patients with no anemia, only patients with severe anemia were 14.29 times 
(95% CI 1.22, 167.9) more likely to be readmitted. When compared to patients whose 
cardiac presentation at admission was angina equivalent, those with non-ST elevation 
myocardial infarction (NSTEMI) were .16 times (95% CI .03, .98) more likely to be 
readmitted, and those with ST elevation MI (STEMI) were .11 times (95% CI .01, .94) 
more likely to be readmitted. When compared to patients with an urgent or emergent 
surgery reason of AMI, ongoing ischemia, USA, worsening CP, rest angina, or syncope, 
those with an urgent or emergent surgery reason identified as anatomy, intra cardiac mass 
or thrombus, or a valve dysfunction were 4.61 times (95% CI 1.28, 16.61) more likely to 
be readmitted. Finally, patients who had an IABP were 3.12 times (95% CI 1.53, 6.38) 






The purpose of this multi-center cross-sectional study was to retrospectively 
examine the relationship between preoperative anemia (hb < 13g/dL) and 30-day hospital 
readmission among adult postoperative open-heart patients. To accomplish the objective 
of this study, the two specific aims of this research were to estimate the prevalence of 
preoperative anemia among adults seeking urgent or elective open-heart surgery and to 
examine the relationship between preoperative anemia, social determinants of health and 
30-day hospital readmission rates among postoperative open-heart adult patients.   
In this study, significant patient characteristics and their association with 
preoperative anemia and 30-day hospital readmission were identified. Data from 1,353 
cases from August 2014 through July 2018 across three acute care community hospitals 
in southern California were extracted and examined. Of those, 177 (13%) experienced a 
30-day readmission. 
Prevalence of anemia. In this study, the prevalence of adult patients with 
preoperative anemia was 44%, which is consistent with previous reports examining 
anemia in the adult cardiac surgery population (Dai et al., 2018; Hubert et al., 2019; 
Karkouti et al., 2008; Kulier et al., 2007; Musallam et al., 2011; Nuis et al., 2013). 
Among those with anemia, 28% were classified as mild, 15% as moderate, and 1% as 
severe. This distribution of preoperative anemia is similar to findings reported in the 
literature (Nuis et al., 2013).   
Preoperative anemia and sociodemographics. Cases of preoperative anemia 




by region. Patients from Hospital A typically reside within the “south” region of southern 
California, while Hospital B’s patients are located in the “east” and “outside county east.”  
 
Figure 3.2. Cases of preoperative anemia by hospital facility. 
 




Study findings indicated the prevalence of preoperative anemia was higher in 
Hispanic, Black, and Asian/Pacific Islander patient populations. Burton et al. (2019) 
concluded preoperative anemia may not only be associated with racial differences and a 
higher comorbidity burden but may also increase the likelihood of postoperative 
morbidity and mortality. This study did not examine the relationship between race and 
morbidity and mortality directly.  
Three quarters of the cases in this study identified Medicare (76%) as the primary 
payor. Considering Medicare is available to persons 65 years and older and the majority 
of adult patients undergoing open-heart surgery are also 65 and older, it is no surprise 
Medicare is the primary payor (Karkouti et al., 20018; Nuis et al., 2013).  
Gender plays a key role in preoperative anemia and postoperative morbidity and 
mortality outcomes. While there were more male than female cases in this study, the 
female patient population had a higher incidence of preoperative anemia. Raju, 
Eisenberg, Montbriand, and Roche-Nagle (2018) noted an association between 
preoperative hemoglobin levels of both genders and in-hospital mortality, adverse cardiac 
events, and postoperative complications, with males having a higher risk overall.   
Preoperative anemia and surgical timing. Little is known about the influence of 
surgical admitting source and clinical outcomes among patients undergoing open-heart 
surgery. In this study, patients who admitted to the hospital for surgery electively had a 
lower preoperative anemia rate than patients admitted through the emergency department 
or as an outside transfer from another facility. Additionally, patients who required open-
heart surgery urgently had a higher prevalence of preoperative anemia than their 




Preoperative anemia and transfusion. Patients with preoperative anemia are at 
a higher risk for red blood cell transfusion both perioperatively and postoperatively. Red 
blood cell transfusion itself is associated with adverse clinical outcomes (Hubert et al., 
2019; Mirzaei, Hershberger & DeVon, 2019). This is consistent with the findings of this 
study, which showed an association exists between preoperative anemia and red blood 
cell transfusion both perioperatively and postoperatively. 
Guidelines for blood product use in cardiac surgery patients have been established 
for well over a decade in the United States. Ferraris et al. (2007) identified six variables 
to serve as critical indicators of risk: (a) advanced age, (b) low preoperative red blood cell 
volume (preoperative anemia or small body size), (c) preoperative antiplatelet or 
antithrombotic drugs, (d) preoperative or complex procedures, (e) emergency operations, 
and (f) noncardiac patient comorbidities. In this study, patients identified as anemic 
preoperatively had a much higher probability of receiving blood product transfusion 
perioperatively. Only 37% of patients with no anemia received a perioperative 
transfusion, compared to 57% of patients with mild anemia, 83% of patients with 
moderate anemia, and 89% of severely anemic patients (Hung, Besser, Sharples, Nair, & 
Klein, 2011; Karkouti et al., 2008; Von Heymann et al., 2016). Many of the patients who 
received blood product transfusions in this study met several if not all six criteria.  
Implementation of risk prediction instruments that contain evidenced-based 
transfusion risk criteria is critical for improved patient outcomes. Blood management 
programs now exist worldwide and are aimed at helping organizations and 
multidisciplinary clinicians examine their current practices and opportunities for 




blood management program has been shown to reduce adverse patient outcomes and 
provide organizations considerable cost savings (Gross, Seifert, Hofmann, & Spahn, 
2015; Leahy et al., 2017; Meybohm et al., 2016; Scolletta et al., 2019). Reviewing 
patients’ risk factors for blood product transfusion, including anemia, and providing 
treatment preoperatively is key. Jin el al. (2019) examined the benefits of intravenous 
iron administration on preoperative anemic patients, and findings showed a reduction in 
blood product transfusions and a correlation with decreased length of stay. Local policies 
and procedures should include such practices in attempt to improve patient outcomes.  
Preoperative anemia, hospital discharge, and readmission. Upon examination 
of the results, the investigator identified a higher percentage of patients with preoperative 
anemia being discharged to an extended care or transitional unit, nursing home, or other 
acute care facility. There is a dearth of literature specifically examining the association 
between preoperative anemia and discharge locations; nonetheless, it can be assumed 
patients discharging to a facility other than home are likely fairly ill, requiring extended 
care from licensed professionals.  
Cho et al. (2019) suggest an association exists between patients with severe 
anemia (hb < 8g/dL) at discharge and 30-day hospital readmission. The current study’s 
findings also found patients identified as having anemia preoperatively were more likely 
to incur a 30-day readmission. Of patients who were readmitted to the hospital within 30 
days, those identified as having preoperative anemia were more likely to return to the 
hospital for an anticoagulation problem, chest pain, congestive heart failure, deep vein 
thrombosis (DVT), infection of the conduit harvest site, pericardial effusion, respiratory 




related. To date, the investigator has not found literature examining the association 
between preoperative anemia and the reasons specified for 30-day hospital readmission. 
This information provides valuable insight into the potential post-discharge problems 
preoperative anemic patients may face and begs the question, “Could these complications 
be avoided if anemia were treated either during the hospitalization or post-discharge, if 
not preoperatively?” 
Strengths and Limitations 
A cross-sectional study design was particularly suitable for this study as the 
research question sought to understand the prevalence of preoperative anemia in the adult 
cardiac surgery population. The study design allowed the investigator to examine 
multiple risk factors, including sociodemographic, and assess more than one outcome. A 
G-Power analysis was run using 90% confidence and two-tailed, .05 significance values. 
With over 80 variables included, the estimated number of cases needed for this study was 
1,288. Over a four-year period, August 2014 through July 2018, the study yielded an 
adequate sample size of 1,353 cases. 
This study examined several demographic, comorbidity, surgical, and transfusion 
criteria; nonetheless an important limitation to this study is the lack of adjustment for 
perioperative and postoperative surgical bleeding. Tauriainen, Koski-Vähälä, Kinnunen, 
and Biancari (2017) found adverse events were no longer associated with preoperative 
anemia when adjusted for key baseline criterion, procedural components, surgical 
bleeding, and blood product transfusion.  
The STS refer to Data Managers as the primary source of data input. Data 




manage the data input process. However, the accuracy of the collected data may be at 
risk. To the best of the investigator’s knowledge, no interrater reliability testing has been 
performed. The investigator could not validate the accuracy of the data set values.    
Conclusion 
Patients with preoperative anemia are more likely to be readmitted to the hospital 
within 30 days of discharge than those without anemia. Health care providers have the 
opportunity to promote positive outcomes through assessment, treatment, and evaluation 
of anemia preoperatively. Routine preoperative blood work should be closely examined 
for the presence of anemia, followed by treatment if indicated. Further research is needed 




Appendix A. Study Variables Evaluated in the Analyses 
 Categorical Variables 
1.  Patient gender 
2.  Patient ZIP code 
3.  Race w/Hispanic as a category 
4.  Hospital Name 
5.  Primary Payor 
6.  Primary Payor Medicare Fee For Service 
7.  Admission source 
8.  RF: Diabetes 
9.  RF: Dyslipidemia 
10.  RF: Hypertension 
11.  RF: Tobacco Use 
12.  RF: Prior Cardiovascular accident 
13.  RF: Preop Anemia 
14.  RF: Prior cardiac intervention 
15.  RF: Prior MI 
16.  RF: Cardiac presentation symptoms at admission 
17.  Meds: ADP Inhibitors w/in 5 days 
18.  Meds: Aspirin w/in 5 days 
19.  Meds: Glycoprotein IIb/IIIa Inhibitor w/in 24 hours 
20.  Meds: Anticoagulants w/in 48 hours 
21.  Meds: Warfarin (Coumadin) w/in 5 days 
22.  Meds: Factor Xa Inhibitors w/in 5 days 
23.  Meds: Novel Oral Anticoagulant w/in 5 days 
24.  Meds: Thrombin Inhibitors w/in 5 days 
25.  Meds: Thrombolytics w/in 48 hours 
26.  Surgery status 
27.  Urgent or emergent reason 
28.  Intraop Blood Products 
29.  Intraop Blood Products: RBC Units 
30.  Intraop Blood Products: FFP Units 
31.  Intraop Blood Products: Platelet Units 
32.  Intraop Blood Products: Cryo Units 
33.  Intraop Antifibrinolytic Meds: Epsilon Aminocaproic Acid 
34.  Intraop Antifibrinolytic Med: Tranexamic Acid 
35.  Coronary Artery Bypass (CAB) 
36.  Cardiopulmonary Bypass (CPB) utilization 
37.  VS: Valve 
38.  VS: Aortic Valve Procedure 
39.  VS: Mitral Valve Procedure 
40.  Blood Products 
41.  Blood Products: RBC Units 




Appendix A (continued) 
 Categorical Variables 
43.  Blood Products: Platelet Units 
44.  Blood Products: Cryo Units 
45.  Initial ICU Hours 
46.  Readmission to ICU 
47.  Postop Intra-Aortic Balloon Pump (IABP) 
48.  Postop Sternal-Superficial Wound Infection 
49.  Postop Deep Sternal Infection / Mediastinitis 
50.  Postop Conduit Harvest 
51.  Postop Wound Intervention / Procedure 
52.  Postop Renal-19 
53.  Postop Renal-Dialysis Required 
54.  Postop Dialysis Required After Discharge 
55.  Postop Other-Card Arrest 
56.  Postop Other-A Fib 
57.  Mortality 30d Status 
58.  Discharge Location 
59.  Readmission (30d from hosp d/c) 
60.  Readmission reason (28cat) 
 Continuous Variables 
61.  Patient age 
62.  RF: Patient BMI (kg/m2) 
63.  RF: Hemoglobin 
64.  RF: Last Creat Level 
65.  RF: Total Albumin 
66.  RF: Last A1c Level 
67.  Hemo Data-EF 
68.  Intraop Blood Products: RBC Units 
69.  Intraop Blood Products: FFP Units 
70.  Intraop Blood Products: Platelet Units 
71.  Intraop Blood Products: Cryo Units 
72.  Postoperative Peak Glucose 
73.  Postoperative Creatinine Level 
74.  Postoperative Hemoglobin 
75.  Blood Products: RBC Units  
76.  Blood Products: FFP Units 
77.  Blood Products: Platelet Units 
78.  Blood Products: Cryo Units 
79.  Initial ICU Hours 
80.  Total OR Time (Hours) 
81.  Admission to Discharge LOS (Days) 
82.  Surgery to Discharge LOS (Days) 
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Aims: The aims of this policy analysis are to explain the development and impact of the 
Hospital Readmission Reduction Program and to discuss the political, social, and 
economic implications of coronary artery bypass grafting as a newly targeted condition 
within the Hospital Readmission Reduction Program. 
Background: Open-heart surgery yields a very high index cost, more than $149,000, and 
has an associated length of stay averaging 9.2 days. Compared to all condition 
readmissions, patients who had CABG procedures had the second highest average 
Medicare payment per readmission at $8,136, an annual cost of $151 million. 
Implementation of the U.S. Patient Protection and Affordable Care Act (ACA) in 2010 
provided government agencies with structures and processes to hold hospitals 
accountable for improving the quality of care delivered, while reducing health care costs. 
Safety net hospitals may be at risk for disproportionate fines due to social factors beyond 
their control. 
Design: Policy analysis.  
Data Sources: Peer reviewed literature was gathered using PubMed and CINAHL 
databases. Additional information was retrieved from AARP, AHRQ, CMS, 
Commonwealth Fund, DHHS, HRSA, Kaiser Family Foundation, and the Library of 
Congress. 
Methods: The paper is presented in accordance with Bardach and Patashnik’s eight-step 
policy analysis procedure. 
Results: Safety-net hospitals (SNH) that care for a much higher rate of disadvantaged 




healthy and out of the hospital. Unsurprisingly, these SNHs are proportionally receiving 
too many higher penalties (44%) compared to non-SNHs (30%), stimulating the need for 
re-evaluation of current penalty programs and formulas. Through examination of the 
evidence addressing the associations between insurance and 30-day hospital readmissions 
following a CABG procedure, penalty programs may be adjusted to better capture 
sociodemographic differences. 
Conclusions: Patients undergoing CABG procedures are faced with a higher than normal 
likelihood of experiencing a hospital readmission 30 days following discharge. One 
strategy to improve morbidity and reduce hospital readmissions among postoperative 
CABG patients is to first identify those who are potentially at high risk for poor 
outcomes. Nurses are well positioned to lead changes in these upstream issues, including 
surgical risk assessments and transitions in care across the continuum. 
Keywords: Hospital Readmission Reduction Program, HRRP, Value-Based 




Coronary Artery Bypass Grafting and the Hospital Readmission Reduction Program 
In 2008, health care costs soared to $2.4 trillion annually, averaging $7,868 per 
capita, the highest in the world (Kaiser Family Foundation, 2008). Open-heart surgery 
alone yields a very high index cost of more than $149,000 and has an associated length of 
stay averaging 9.2 days (Mozaffarian et al., 2016). Compared to all condition 
readmissions, coronary artery bypass graft (CABG) patients had the second highest 
average Medicare payment per readmission at $8,136 per visit, an annual cost of $151 
million (Medicare Payment Advisory Committee [MedPAC], 2007). The two aims of this 
analysis, which utilizes Bardach and Patashnik’s (2016) eight-step policy analysis 
procedure, are to explain the development and impact of the Hospital Readmission 
Reduction Program (HRRP), and to discuss the political, social, and economic 
implications of CABG as a newly targeted condition within the HRRP. 
Defining the Problem 
Implementation of the U.S. Patient Protection and Affordable Care Act (ACA) in 
2010 provided government agencies with structures and processes to hold hospitals 
accountable for improving the quality of care delivered and reducing health care costs. 
While tremendous improvements have been made in several areas of health care as a 
result of the ACA (e.g., increased access to care, decreased uninsured Americans, reduced 
readmission rates, and slowed growth of health care costs), disparities in quality care and 
outcomes persist (Adepoju, Preston, & Gonzales, 2015; Chen, Vargas-Bustamante, 
Mortensen & Ortega, 2016; French, Homer, Gumus, & Hickling, 2016; Martin, Hartman, 
Whittle, Catlin, & National Health Expenditure Accounts Team, 2014). Contributing 




uneven distribution of resources devoted to performance improvement efforts, and an 
overall sicker population (Lewis, Fraze, Fisher, Shortell, & Colla, 2017). The Department 
of Health and Human Services (DHHS; 2015) reported 62% of high-income hospitals 
paid $78 million in penalties, compared to 85% of low income hospitals that absorbed 
$117 million dollars in penalties (see Figures 4.1 and 4.2).  
Low socioeconomic status is directly linked to increased morbidity and mortality; 
notably, individual costs associated with health care coverage and out-of-pocket expenses 
are leading barriers to consumption of health care services (Adepoju et al., 2015; Adler & 
Newman, 2002). Safety-net hospitals (SNH) that care for a much higher rate of 
disadvantaged and uninsured patient populations have struggled to develop solutions to 
keep patients healthy and out of the hospital. Unsurprisingly, these SNHs are 
proportionally receiving too many higher penalties (44%) compared to non-SNHs (30%), 
stimulating the need for re-evaluation of current penalty programs and formulas (Carey & 






Figure 4.1. Hospitals incurring an HRRP penalty by DPP quartile, FY 15 (DHHS). 
Note: Highest income hospitals received $78 million dollars in readmission penalties, compared to the $117 




Figure 4.2. Percent penalized by HRRP by DPP quartile FY 15 (DHHS). 
Note: 62% of highest income hospitals received readmission penalties, compared to 85% of hospitals with 
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Assembly of Evidence 
Throughout the 2008 election year, health care reform became a significant topic 
during political debates. Once elected, in response to the need for reduced unnecessary 
health care spending and improved quality care, President Obama and his cabinet spent 
the following year gathering teams of experts who methodically drafted a newly designed 
health care model. Through strong commitment, neutralization of interest group 
opposition, and carefully calculated advancement of the legislation through a polarized 
partisan government, on March 21, 2010, the U.S. Patient Protection and Affordable Care 
Act (ACA) was ratified (Rubin, 2011).   
In order to meet the rather hefty legislative goals outlined in the ACA, multiple 
support programs such as the Hospital Acquired Conditions (HAC), Hospital Value-
Based Purchasing Program (VBP), and Hospital Readmission Reduction Program 
(HRRP) were generated. Penalties occur when hospital claims for services rendered are 
paid out. Payment adjustments are applied in a tiered order with the Hospital VBP 
program first, followed by the HRRP, and lastly, the HAC reduction program. The VBP 
and HRRP adjustments are independent of one another and are applied to the base 
operating diagnosis-related group (DRG) payment amount. After applying the VBP and 
HRRP adjustments, the HAC adjustment is then applied to the net result (Wheeler-Bunch, 
Goubeaux, & Thompson, 2016).   
Hospital Value-Based Purchasing (VBP) 
Hospital VBP reimbursement penalties began in FY 2013 at 1% of base operating 
DRGs, met the cap rate of 3% in FY 2015, and continue today (CMS, 2016b). The VBP 




added to the total sum (CMS, 2012). The domains and their associated weights have 
evolved considerably over the past four years to better attain the goals of the ACA (Table 
4.1; CMS, 2012; DHHS, 2015).  
Table 4.1 

















2013 1.00% 20 70% 30% - - - 
2014 1.25% 24 45% 30% 25% - - 
2015 1.50% 26 20% 30% 30% 20% - 
2016 1.75% 24 10% 25% 40% 25% - 
2017 2.00% 21 5%a 25% 25%a 25% 20% 
2018 2.00% 20 - 25% 25%a 25% 25% 
Note: Adapted from https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-
MLN/MLNProducts/downloads/Hospital_VBPurchasing_Fact_Sheet_ICN907664.pdf 
a Process of Care and Outcome measures were combined into a Clinical Care measure 
 
Hospital Readmission Reduction Program (HRRP) 
Program overview. With the initiation of the HRRP, the focus on clinical care 
and outcomes have driven hospitals to reexamine health care delivery. Beginning in 
October 2012, HRRP began tying patient outcomes to reimbursement for care provided 
as the CMS (2016a) penalized hospitals with high readmission rates among their fee-for-
service Medicare beneficiaries.   
Program penalties and measures. Although readmission rates have fallen 
considerably since 2012, rates for targeted conditions identified by CMS dropped more 
quickly than non-targeted conditions (Zuckerman, Sheingold, Orav, Ruhter, & Epstein, 
2016). In FY 2013 and through FY 2014, CMS included three targeted measures: heart 




diagnostic groups were added: chronic obstructive pulmonary disease (COPD), hip 
replacements, and knee replacements. Most recently, in FY 2017, expansion of 
pneumonia performance measures and coronary-artery bypass graft (CABG) were added 
and will continue through FY 2021 (Table 4.2; CMS, 2016b).   
Table 4.2 
Hospital Readmission Reduction Program Overview 
FY Max 
Penalty % 
Total # of 
Measures 
AMIa HFb PNAc COPDd THAe TKAf CABGg 
2013 1.00% 3 + + + - - - - 
2014 2.00% 3 + + + - - - - 
2015 3.00% 6 + + + + + + - 
2016 3.00% 6 + + + + + + - 
2017 3.00% 7 + + + + + + + 
2018 3.00% 7 + + + + + + + 
Note: Adapted from https://www.cms.gov/medicare/medicare-fee-for-service-
payment/acuteinpatientpps/readmissions-reduction-program.html 
 
a Acute Myocardial Infarction 
b Heart Failure 
c Pneumonia 
d Chronic Obstructive Pulmonary Disease  
e Total Hip Arthroplasty 
f Total Knee Arthroplasty 
g Coronary Artery Bypass Graft 
 
In FY16 alone, roughly $420 million in penalties were rendered against 2,600 
hospitals for excess 30-day readmissions (Studer Group, 2016). CMS adjusts data related 
to various demographic characteristics (e.g., xx), then proceeds to calculate a rate of 
excess readmissions. An examination of Accountable Care Organizations (ACOs) shows 
organizations with higher racial and ethnic diversity score worse on performance 
measures—more specifically, scoring much lower on 25 of the 33 measures (Lewis et al., 




In 2014, legislators proposed a set of bills requiring CMS to include 
sociodemographic influences such as age, medical history and other medical conditions 
in the risk-adjustment methodology embedded in the HRRP. One bill encouraged CMS to 
examine the potential of expansion of readmission exclusions with the impetus that some 
patient diagnoses require frequent hospitalizations and some patients are non-compliant, 
behavior that is out of the providers’ control (American Hospital Association [AHA], 
2015). 
More recently, legislation has been ratified to better protect hospitals with higher 
portions of low-income beneficiaries as well as large teaching hospitals, which have been 
shown to receive disproportionate shares of penalties. Adjustments are provided for 
socioeconomic demographics, including patients who are dually qualified for full 
Medicare and full Medicaid (Boccuti & Casillas, 2017).   
Coronary artery bypass graft measure (CABG). The CABG measure’s first 
performance period began July 1, 2017 and will conclude around December, 2021 after 
five years. The CABG measure model differs from previous measures as it is part of an 
Innovation Model in CMS that will take a bundled care approach and initially only be 
implemented in 98 metropolitan statistical areas (MSAs), including approximately 1,120 
hospitals (CMS, 2017). The episode of care begins with hospital admission and concludes 
90 days following discharge. Although hospital readmission has not been linked as an 
independent prognosticator of short-term mortality, readmission data related to cardiac 
surgery has been substantially high historically (13-18%) and has yet to waver (Hannan et 




Interest in identifying readmission measures specifically related to surgical 
patients has grown. Merkow et al. (2015) utilized a dataset from the American College of 
Surgeons National Surgical Quality Improvement Program (ACS NSQUIP) to examine 
the timing and reason for unplanned readmissions. This prospective study captured 
498,875 patients from 346 ACS NSQUIP-associated institutions who underwent bariatric 
surgery, colectomy/proctectomy, hysterectomy, total hip/knee arthroplasty, ventral hernia 
repair, and lower extremity vascular bypass in 2012. Across all procedural groups, 5.7% 
had an unplanned readmission with a median time to readmission of 8 days and an 
average length of stay of 1 day.  Surgical site infection was the leading cause of 
readmission (19.5%) with ileus or intestinal obstruction as the second (10.3%). Bleeding 
and anemia were analyzed together, making up the third leading cause of readmission at 
4.3% (Merkow et al., 2015).  
Focused attention on quality of care delivered to CABG patients is necessary to 
improve clinical outcomes. Adding CABG to the growing list of CMS-targeted 
conditions is certainly a step in the right direction; however, design of the inclusion and 
exclusion criteria is crucial for success. 
Constructed Alternatives 
Since the initiation of HRRP in 2012, hospital readmissions have continued to be 
a costly source of concern for many health care organizations. A number of possible 
alternatives to reduce readmissions exist. First, as risk predictive models expand, such a 
model would provide organizations with a structure to create processes for identifying 
and potentially avoiding hospital readmissions following cardiac surgery. Efforts should 




as factors for increased risk of readmission among post-cardiac surgical patients are 
identified, use of the care transitions model may also prove helpful in further augmenting 
post-discharge care and avoiding preventable readmissions (Goldstein, Hicks, Kolm, 
Weintraub, & Elliott, 2016). Finally, through the examination of factors contributing to 
the variation in 30-day hospital readmissions following a CABG procedure, a factor-
adjusted (e.g., sociodemographic differences) penalty program may be more appropriate.  
Predictive Models 
One strategy to improve prediction of morbidity and reduce hospital readmissions 
among postoperative CABG patients is to first identify those patients who are potentially 
at high risk for poor outcomes. Federal mandates for a comprehensive approach to 
reducing morbidity and readmissions through the use of evidenced-based predictive 
models may be a viable option. Patients presenting with multiple comorbidities 
preoperatively, such as anemia, hypertension, diabetes, heart failure, depression, and 
alcohol abuse, have a higher rate of morbidity and mortality postoperatively (Humphreys, 
Denson, Baker, & Tully, 2016; Koch, Weng, Zhou, Savino, Mathew, et al., 2003). 
Nashif et al. (1999) first published the European system for cardiac operative risk 
evaluation instrument (EuroSCORE) that has since aided cardiothoracic surgeons in 
surgical decision-making, preoperative informed consent, quality assurance, and health 
care management (Yap et al., 2006). The validity of the EuroSCORE has been tested in 
tens of thousands of patients and across other countries such as Spain, Turkey, and 
Australia. While some studies have found its validity satisfactory, overestimation in 
mortality among high-risk patients has been consistent, requiring clinicians and 




Researchers in Columbia considered the addition of hemoglobin and B-type natriuretic 
peptide (BNP) to the EuroSCORE to see if the predictive power of morbidity and 
mortality would be increased for both index hospitalizations and 60-day readmissions. 
Hernández Leiva, Dennis, Isaza, and Umaña (2013) reviewed data on 492 patients, 
looking at the predictability of hemoglobin and BNP independently against the 
EuroSCORE, then they incorporated the variables into the EuroSCORE itself. Findings 
showed that independently, neither hemoglobin nor BNP were strong predictors of 
morbidity or mortality. When both variables were integrated, the EuroSCORE increased 
prediction of morbidity, particularly transfusion; however, mortality predication was not 
significantly improved.   
Espinoza et al. (2016) published a simplified risk prediction instrument that could 
be used to better identify patients at high risk for early hospital readmission following 
open-heart surgery. The instrument was tested and validated in Argentina on more than 
5,000 patients (AUC 0.639 [95% CI 0.606 to 0.672]). The instrument procedure includes 
a review of the preoperative hematocrit, with a value of <35% preoperatively considered 
high risk. Other items on the instrument include a history of diabetes mellitus, minutes 
spent on-pump, highest serum glycemic level, and atrial fibrillation postoperatively. The 
authors admitted the instrument was limited by poor exploration of preoperative anemia, 
and they discussed the association between acute kidney injury (AKI) and anemia, with 
supporting evidence that AKI is a precursor to other risk factors associated with hospital 
readmission. Using multivariate analysis for determining readmission risk, results 
showed neither preoperative renal failure nor postoperative acute kidney injury were 




preoperative anemia alone, uni- and multivariate analysis showed a significant 
association with hospital readmission (Espinoza et al., 2016).  
While some instruments have been shown to overestimate the morbidity and 
mortality risk of preoperative candidates, mandatory implementation of a validated risk 
predictor instrument during preoperative assessment remains a promising approach to 
decrease readmissions and morbidity upstream by preventing high-risk patients from 
undergoing risky surgery in the first place. 
Care Transitions Programs 
Care transitions programs have demonstrated effective reduction in overall 
hospitalizations (11%) and hospital readmissions (15%) among Medicare beneficiaries 
(Lynn, 2014). Nurse practitioners who provided follow up care at the patient’s home 
following CABG procedures significantly reduced 30-day readmission/death rate 
(3.85%) compared to usual care (11.54%; Hall et al., 2014). Older adults undergoing 
CABG surgery are at an increased risk for depression and decreased functional status 
(Sorenson & Wang, 2009). Physical therapists have carved a role into care transitions 
programs through improving functional status of discharged CABG patients in the home 
setting (Arthur, Smith, Kodis, & McKelvie, 2002). Providing state and federal funding 
for care transition programs could stimulate creation and utilization of such programs and 
further reduce undesired patient outcomes.   
Adjusting for Factors 
Readjustments for age, medical history, and other medical conditions currently 
exist in the adjustment methodology within cardiac surgery risk prediction instruments 




hospital readmission risk. Some experts working in CMS and the National Quality Forum 
(NQF) argue adjusting for sociodemographic factors may mask disparities through the 
softening of penalties and lowering of standards and could unintentionally deter 
incentives to improving health outcomes for disparate populations (AHA, 2015; U.S. 
Government Publishing Office [GPO], 2016). While this concern is valid, funding is at 
risk for safety-net hospitals that primarily care for patients holding state and federal 
insurance, and funding will be at even greater risk when Medicare-Medicaid funding is 
cut for disparate groups through decreased insurance coverage while the penalty 
methodology remains the same.   
Postoperative patients with Medicare-Medicaid insurance have increased 
mortality rates and longer hospitalizations and are more likely to have multiple 
comorbidities preoperatively with fewer resources postoperatively (Herrel, Wong, Ye & 
Miller, 2016). While adjusting penalties for facility-specific payor mix may not 
drastically improve patient outcomes, an adjustment for patients with Medicare-Medicaid 
insurance has been shown to better represent socioeconomic disparities and predict 
readmissions (Anderson, Li, Romano, Parker, & Chang, 2016). After taking patients’ 
poverty status into consideration within the calculated adjustment methodology, Missouri 
hospitals’ readmissions rates showed marked improvement (43% to 88%; Gillespie, 
2016). 
Select the Criteria 
The CMS reported that section 3025 of the Affordable Care Act required 
establishment of the HRRP to reduce payments to Inpatient Prospective Payment System 




CMS, 2016a). Using the risk adjustment methodology sanctioned by the National Quality 
Forum, readmissions measures were calculated as a ratio of X to Y and were fine-tuned 
taking into consideration clinically appropriate components including specific “patient 
demographic characteristics, comorbidities, and patient frailty” (CMS, 2016a). For FY 
2013, the maximum penalty for excess 30-day hospital readmission was set at 1%. The 
penalty increased incrementally to 2% in FY 2014 and reached a cap of 3% in FY 2015, 
which remains today.   
Historically, the health care system has taken extensive time to implement 
comprehensive programs that address patient outcomes (CMS 2016a). Since the initiation 
of the HRRP, concentrated efforts focusing on the reduction of morbidity and 
readmissions have pushed hospitals to implement risk reduction programs at a much 
quicker pace, and results show favorable outcomes in decreased costs and improved 
quality of life (Keenan et al., 2008). With the addition of CABG as a targeted measure, it 
can be expected readmission rates will decrease; however, sociodemographic data must 
be considered, as many patients will present with multiple comorbidities and have poor 
compliance, thus challenging which outcomes are truly within the control of health care 
providers.   
Decreasing readmissions among the postoperative CABG population—through 
increased accountability efforts designated by the HRRP and implementation of a care 
transition approach—is likely to have profound effects similar to or perhaps greater than 
those of other established CMS-targeted conditions. Organizations providing open-heart 
surgical services must be prepared to redesign their programs to incorporate additional 




negative downstream consequences for example hospital readmissions. In addition, 
increased interprofessional collaboration will provide patients with enhanced 
comprehensive care throughout their hospitalization and even following them home, thus 
optimizing patient recovery and preventing readmissions. Nurses, including advanced 
practice nurses (APRNs), must be empowered to maximize processes where care can be 
rendered effectively and efficiently throughout patient episodes of care. 
Projected Outcomes 
In 2007, the Medicare Payment Advisory Commission (MedPAC) presented 
Congress with a report outlining the top seven potentially preventable medical conditions 
(MedPAC, 2007). Of the seven, CABG ranked among the top potentially preventable 
readmission conditions at 13.5% (Yale New Haven Health Services Corporation/Center 
for Outcomes Research & Evaluation [YNHHSC/CORE], 2014).  
The volume of CABG procedures has been consistently declining since the mid 
2000s. In 2014, the Society of Thoracic Surgeons (2015) counted more than 171,000 
isolated and combined CABG procedures across the United States. At an average 
readmission rate of 13.5%, this would account for 23,085 30-day hospital readmissions 
annually. Although predictions have not been set for the reduction of CABG 
readmissions, we can examine the performance of previously set targeted conditions to 
gain a better understanding of how CABG readmissions might change. Between 2006 
and 2014, readmission rates fell for heart failure by 11% (24.8 to 22.0), myocardial 
infarction by 14.6% (19.9 to 17.0), and pneumonia by 8.6% (18.5 to 16.9; Boccuti & 
Casillas, 2017). Applying these reduction rates (8.6-14.6) to the CABG population would 




Even though it is not known what percentage of CABG patients are living in 
poverty, we can estimate the majority are likely covered by Medicare-Medicaid, had 
complex comorbidities prior to surgery, and had reduced resources postoperatively. 
Incorporation of social demographics into the calculated adjustment methodology would 
certainly lower the overall readmission rate penalties. 
Confronting Trade-Offs 
Mandated application of predictive models into preoperative assessments can 
reduce the number of patients with poor surgical outcomes, including hospital 
readmissions. However, this also means the number of surgical cases will likely decline 
overall because patients may no longer be candidates for surgery according to 
preoperative assessment findings. CABG surgery is a very profitable service for many 
hospitals. Reduction in cases will lead to less profit upfront, but the downstream effect is 
that fewer reimbursed dollars will be spent on readmission care, and penalties must be 
considered.  
Implementation of a care transition program will be costly up front; program 
development, staffing, and work flow will need to be addressed. Restructuring patient 
discharges to create more effective transitions in care will likely modify the current roles 
of various professionals that may be an initial barrier to successful change. Over time and 
when role competence is achieved, the transition of care should be efficient and result in 
improved outcomes, including declining readmission rates.   
Adjusting for reimbursement models for insurance to help relieve safety-net 
hospitals from burdening financial penalties may diminish hospitals’ efforts to create and 




for safety-net hospitals, cost avoidance savings may drive readmission reduction 
processes, including preventative care efforts, resulting in worse outcomes.  
Recommendations 
The 2011 Institute of Medicine (IOM) report charges nurses to become full 
partners with physicians and other health care professionals in the redesign of health care 
in the United States. To improve quality of care and patient outcomes, nurses must 
become creative in our solutions and strengthen our voice. With over 3.1 million nurses 
practicing across a wide variety of settings, we are familiar with deficits in health care, 
resource limitations, and patient needs. This knowledge can drive the development of 
meaningful programs. Creating preventative care programs designed to reach patients in 
lower socioeconomic areas can improve overall population health by reducing 
comorbidities and devastating chronic illnesses.  
Implementation of predictive care models in cardiovascular surgical programs can 
assist providers in proactively mitigating potential complications identified through 
preoperative assessment using evidence-based predictive assessment instruments. Nurses 
functioning as case managers for these patients can assist in the application of predictive 
care models through patient assessment and delivery of formal recommendations to 
consulting physicians.   
Application of strong transitions of care programs can influence patient behaviors 
to improve compliance and long-term health. Both RNs and APRNs certainly have a role 
within these programs. From assessing and teaching to diagnosing and treating, nurses 






Patients undergoing CABG procedures are faced with a higher than normal 
likelihood of experiencing a hospital readmission 30 days of discharge. As hospitals work 
to improve readmission rates, upstream determinants must be carefully assessed and 
addressed to see positive downstream changes. It is imperative policy makers include 
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DISCUSSION OF FINDINGS 
Background and Study Purpose 
Each year, more than 500,000 cardiac surgery procedures take place in the United 
States (Texas Heart Institute, 2019a). While the number of coronary artery bypass graft 
(CABG) procedures has decreased over the years, they still comprise nearly half of all 
adult open-heart surgery procedures at more than 200,000 surgeries annually (Benjamin 
et al., 2018; Texas Heart Institute, 2019a). In contrast, valve-related procedures are 
steadily increasing in numbers, contributing to more than 106,000 procedures per year 
(Texas Heart Institute, 2019b). As the U.S. baby boomer population continues to age, the 
number of cardiac-related procedures is expected to increase significantly. Federal efforts 
to improve access to care, the patient experience, and better outcomes afforded by lower 
costs have shifted the way organizations do business. Deemed a performance measure by 
the Centers for Medicare and Medicaid Services (CMS) in 2017, efforts to improve 
patient outcomes following coronary artery bypass surgery have become a focus for U.S. 
hospitals.  
Hospital readmissions among cardiac surgery patients are higher than most 
surgical procedures and contribute a significant financial burden to individuals and the 
health care system (Hannan et al., 2011; Mozaffarian et al., 2016; Sargin et al., 2016). A 
common criticism of CMS’ Hospital Readmission Reduction Program (HRRP) is its lack 
of attention to safety-net hospitals. Efforts have been made to create and refine risk 
prediction models that could better direct clinicians in their approach to patient care. 




of potential confounding variables to take into consideration, a few well-tested models do 
exist in practice today (D’Agostino et al., 2018). Inclusion of sociodemographics within 
risk predication models may add value to the accuracy of risk calculations and better 
support safety-net hospitals who care for underserved populations. 
Synthesis of Dissertation 
Application of Condition-Based Maintenance: A Concept Analysis 
Chapter 2 presented a concept analysis completed using Walker and Avant’s 
(2011) eight-step concept analysis procedure. When deriving a concept for analysis 
related to the topics of symptom science and hospital readmissions, concepts and models 
were examined from a wide range of industries that dealt with the general idea of 
“maintenance” and “failure” within their field. Articles within engineering were 
overwhelmingly filled with maintenance models. These models were examined, and the 
lifespan of equipment and related maintenance was closely reviewed and compared to the 
health care delivery model. However, use of condition-based maintenance has not been 
explored in relation to health maintenance among humans. The aims of the concept 
analysis were to develop an operational definition of the term condition-based 
maintenance as applied to health care and to discuss the applicability and effectiveness of 
condition-based maintenance within health care. 
Condition-based maintenance was defined as an efficient, proactive process 
utilizing monitoring methods to predict, identify, and repair health-related problems 
precisely, therefore lengthening one’s life. Application of the condition-based 
maintenance model may prove to have relevance in reducing hospital readmissions as it 




before an individual experiences a significant decline in health, warranting care. This 
concept analysis advances the NINR’s focus on symptom science through the 
development of personalized strategies to treat and prevent the adverse symptoms of 
illness. It is anticipated this concept analysis will contribute to further identification of 
clinical signs of deterioration and accompanying interventions to prevent hospitalization 
and unnecessary death. 
Preoperative Anemia and 30-Day Hospital Readmission Among Adult Postoperative 
Open-Heart Surgery Patients 
Chapter 3 presented a research study conducted to examine the prevalence and 
postoperative outcomes of iron-deficiency anemia on adults undergoing open-heart 
surgery. To better understand this relationship, the research question of interest was, 
What is the relationship between preoperative anemia (hemoglobin<13g/dL), and 30-day 
hospital readmission among adult postoperative open-heart patients?  
A descriptive, correlational, cross-sectional design was used for the study. This 
design enabled the identification of many interrelationships among variables within a 
specific condition at one point in time. The study provides valuable insights into the use 
of a correlational, cross-sectional study for testing the hypotheses in data related to 
preoperative anemia and surgical outcomes following open-heart surgery in an adult 
population. In this study, significant patient characteristics and their association with 
preoperative anemia and 30-day hospital readmission were identified. In total, 1,353 
cases of surgeries performed between August 2014 and July 2018 were extracted from 
the Society of Thoracic Surgeons National Database for Adult Cardiac Surgery from 




Research aim I. The first research aim was to identify the prevalence of adult 
patients presenting with anemia preoperatively at three community-based hospitals 
located in the southwestern region of the United States. The study found a prevalence rate 
of 44% among adult patients presenting with preoperative anemia, consistent with 
previous research examining preoperative anemia in the adult cardiac surgery population 
(Dai et al., 2018; Hubert et al., 2019; Karkouti et al., 2008; Kulier et al., 2007; Musallam 
et al., 2011; Nuis et al., 2013). Among those with preoperative anemia, 28% were 
classified as mild, 15% as moderate, and 1% as severe. This distribution of preoperative 
anemia was similar to findings reported in the literature as well (Nuis et al., 2013).   
Research aim II.  The second aim examined the relationship between 
preoperative anemia, sociodemographics, and 30-day hospital readmission rates among 
postoperative open-heart adult patients. A total of 177 patients with preoperative anemia 
were readmitted to the hospital within 30 days of discharge. Of the 14 predictor variables, 
only six were identified as statistically significant: (a) hospital admission source, (b) 
hypertension, (c) tobacco use, (d) preoperative anemia, (e) reason for urgent or emergent 
surgery, and (f) intra-aortic balloon pump (IABP). When compared to patients with an 
elective admission to the hospital, those admitted to the hospital through the emergency 
department were 6.86 times (95% CI 2.04, 23.09) more likely to be readmitted to the 
hospital in the first 30-days after hospital discharge; those transferred from another 
hospital, acute care facility, or any other facility were 7.67 times (95% CI 1.82, 32.35) 
more likely to be readmitted. Patients with hypertension were 9.53 times (95% CI 1.86, 
51.47) more likely to be readmitted. Patients who used tobacco products were 2.53 times 




anemia, patients with mild anemia were 2.31 times (95% CI 1.06, 5.01) more likely to be 
readmitted; those with severe anemia were 16.99 times (95% CI 1.42, 201.71) more 
likely to be readmitted. When compared to patients that had an urgent or emergent 
surgery reason of acute myocardial infarction (AMI), ongoing ischemia, unstable angina 
(USA), worsening chest pain (CP), rest angina, or syncope, those with an urgent or 
emergent surgery reason of anatomy, intra cardiac mass or thrombus, or a valve 
dysfunction were 4.46 times (95% CI 1.26, 15.82) more likely to be readmitted. Finally, 
patients who had an IABP were 3.16 times (95% CI 1.55, 6.44) more likely to be 
readmitted.   
Coronary Artery Bypass Grafting and the Hospital Readmission Reduction 
Program  
 As previously stated, the costs and related readmissions associated with open-
heart surgery are considerably high relative to other common surgical procedures 
(MedPAC, 2007; Mozaffarian et al., 2016). Chapter 4, the third manuscript of this 
project, followed Bardach and Patashnik’s (2016) eight-step policy analysis procedure. 
The two aims of this analysis were to explain the development and impact of the Hospital 
Readmission Reduction Program (HRRP) and to discuss the political, social, and 
economic implications of coronary artery bypass grafting as a newly targeted condition 
within the HRRP. The HRRP began penalizing hospitals in FY 2013 on just three 
measures, but since that time the number of measures has grown to seven and the percent 
penalized has climbed from 1% up to 3%.    
CABG procedure was recently added as a targeted measure in FY 2017. Through 




will decrease; however, social demographic data must be taken into consideration as 
many patients will present with multiple comorbidities and poor compliance, thus 
challenging what outcomes are truly within the control of health care providers. 
Adjusting reimbursement models for insurance may help relieve safety-net hospitals from 
burdening financial penalties.   
Discussion 
The concept analysis of condition-based maintenance presented in Chapter 2 
underpins the importance of symptom science through the transposing and trialing of 
established monitoring methods to improve patient safety, increase life-span, decrease 
burden, and decrease health care costs. This concept analysis is considered innovative, 
but it is also abstract in nature. Without applicable empirical referents, further research is 
needed to identify whether condition-based maintenance can be adapted to monitoring 
various human conditions effectively. Additional quantitative and qualitative research 
focusing on both disease-specific measurements and quality of life components could 
further develop the concept in becoming more operational. Outcomes from this analysis 
may be useful in the development and testing of measurement instruments. 
In the empirical study presented in Chapter 3, the prevalence of preoperative 
anemia was 44%, and prevalence was higher in Black, Hispanic, and Asian/Pacific 
Islander patient populations. Burton et al. (2019) concluded preoperative anemia may not 
only be associated with racial differences and a higher comorbidity burden but may also 
increase the likelihood of postoperative morbidity and mortality. This study did not 




The greater part of cases in this study (76%) identified Medicare as the primary 
payor. Considering Medicare is available to persons 65 years and older, and the majority 
of adult patients undergoing open-heart surgery are also 65 and older, it is no surprise 
Medicare is the primary payor (Karkouti et al., 20018; Nuis et al., 2013).  
Gender plays a key role in preoperative anemia and postoperative morbidity and 
mortality outcomes. While there were more male than female cases in this study, females 
had a considerably higher incidence of preoperative anemia, yet readmission rates 
between genders remained relatively equal. Raju et al. (2018) noted an association 
between preoperative hemoglobin levels of both genders and in-hospital mortality, 
adverse cardiac events, and postoperative complications, with males having a higher risk 
overall.   
Little is known about the influence of surgical admitting source and clinical 
outcomes among patients undergoing open-heart surgery. In this study, patients admitted 
to the hospital for surgery electively had a lower preoperative anemia rate than patients 
admitted through the emergency department or as an outside transfer from another 
facility. Additionally, patients who required open-heart surgery urgently had a higher 
prevalence of preoperative anemia than their electively scheduled counterparts.  
Patients with preoperative anemia are at a higher risk for red blood cell 
transfusion both perioperatively and postoperatively that is associated with adverse 
clinical outcomes (Hubert et al., 2019; Mirzaei, Hershberger & DeVon, 2019). This is 
consistent with the findings of this study, showing an association exists between 





Guidelines for blood product use in cardiac surgery patients have been established 
for well over a decade in the United States. Ferraris et al. (2007) identified six variables 
to serve as critical indicators of risk: (a) advanced age, (b) low preoperative red blood cell 
volume (preoperative anemia or small body size), (c) preoperative antiplatelet or 
antithrombotic drugs, (d) preoperative or complex procedures, (e) emergency operations, 
and (f) non-cardiac patient comorbidities. In this study, patients identified as anemic 
preoperatively had a much higher probability of receiving blood product transfusion 
perioperatively. Only 37% of patients who did not have anemia received a perioperative 
transfusion, compared to 57% of patients with mild anemia, 83% of patients with 
moderate anemia, and 89 % of severely anemic patients (Hung et al., 2011; Karkouti et 
al., 2008; Von Heymann et al., 2016). Many of the patients who received blood product 
transfusions in this study met several if not all six criteria.  
Implementation of risk prediction instruments that contain evidenced-based 
transfusion risk criteria is critical for improved patient outcomes. Blood management 
programs now exist worldwide and are aimed at supporting organizations and 
multidisciplinary clinicians examine their current practices and opportunities for 
improvement in their use of blood products (Mueller et al., 2019). Implementation of a 
blood management program has been shown to reduce adverse patient outcomes and 
provide organizations considerable cost savings (Gross, Seifert, Hofmann, & Spahn, 
2015; Meybohm et al., 2016; Leahy et al., 2017; Scolletta et al., 2019). Reviewing patient 
risk factors for blood product transfusion, including anemia, and providing treatment 
preoperatively is crucial. Jin el al. (2019) examined the benefits of intravenous iron 




transfusions and a correlation with decreased length of stay. Local policies and 
procedures should include such practices in attempt to improve patient outcomes.  
Upon examination of the results, the investigator identified a higher percentage of 
patients with preoperative anemia being discharged to an extended care or transitional 
unit, nursing home, or other acute care facility. While there is no literature specifically 
focusing on the association between preoperative anemia and discharge locations, one 
can assume patients discharging to a facility other than home are more ill and require care 
from licensed professionals as a result.  
Cho et al. (2019) suggest an association exists between patients with severe 
anemia (hb <8g/dL) at discharge and 30-day hospital readmission. This was also a 
finding in this study; patients with preoperative anemia were more likely to incur a 30-
day hospital readmission. Of patients readmitted within 30 days, those identified as 
having preoperative anemia were more likely to come back to the hospital for an 
anticoagulation problem, chest pain, congestive heart failure (CHF), deep vein 
thrombosis (DVT), infection of the conduit harvest site, pericardial effusion, respiratory 
complications, sepsis, endocarditis, or other reasons, both surgical and non-surgical 
related. To date, the investigator has not found literature examining the association 
between preoperative anemia and the reasons specified for 30-day hospital readmission.  
This study had several strengths and limitations. A cross-sectional study design 
was particularly suitable for this study as the research question sought to understand the 
prevalence of preoperative anemia in the adult cardiac surgery population. The study 
design allowed the investigator to examine many risk factors, including 




2014 through July 2018, the study yielded 1,353 cases, an adequate sample size 
considering the large number of variables. While this study examined several 
demographic, comorbidity, surgical and transfusion criteria, an important limitation was 
the lack of adjustment for perioperative and postoperative surgical bleeding. This data 
was not included in the STS database extraction because literature supporting its use was 
identified after the database was built. Tauriainen, Koski-Vähälä, Kinnunen, and Biancari 
(2017 found adverse events were no longer associated with preoperative anemia when 
adjusted for key baseline criterion, procedural components, surgical bleeding, and blood 
product transfusion.  
The Society of Thoracic Surgeons refer to data managers as the primary source of 
data input. Data managers review training modules and have access to several online 
resources to help manage the data input process. Nonetheless, caution must be noted for 
the accuracy of the collected data. To the best of the investigator’s knowledge, no 
interrater reliability testing has been performed. The investigator could not validate the 
accuracy of data set values.    
Nursing Implications 
Decreasing readmissions among the postoperative CABG population through 
increased accountability efforts designated by the HRRP is likely to have profound 
effects similar to or perhaps greater than those of other established CMS-targeted 
conditions. Organizations providing open-heart surgical services must be prepared to 
redesign their programs to incorporate additional services (e.g., predictive models and 
care transitions programs) upstream to prevent negative downstream consequences such 




with enhanced comprehensive care throughout their hospitalization and even following 
them home, thus optimizing patient recovery. Nurses, including advanced practice nurses 
(APRNs), must be empowered to maximize processes where care can be rendered 
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